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ABBREVIATIONS USED IN THE STUDY 
 
GDM   - Gestational Diabetes Mellitus 
Zn   - Zinc 
Mg   - Magnesium 
OGTT   - Oral Glucose Tolerance Test 
IDDM   - Insulin Dependent Diabetes Mellitus 
NIDDM  - Non Insulin Dependent Diabetes Mellitus 
DM   - Diabetes Mellitus 
NGT                           -           Normal  Glucose  Tolerance 
IGT                            -            Impaired  Glucose  Tolerance 
IFG                            -            Impaired  Fasting  Glucose 
GLUT 2                      -           Glucose  Transporter 2 
IRS   - Insulin Receptor Substrate 
IRTK                          -           Insulin  Receptor  Tyrosine  Kinase 
OG   - Obstetrics and Gynecology  
ADA   - American Diabetes Association 
WHO   - World Health Organization 
CDC                           -           Centre  for  Disease  Control 
BMI   - Body Mass Index 
ATP   - Adenosin Tri Phosphate  
PCOD   - Poly Cystic Ovarian Disease  
LMP   - Last Menstrual Period 
GA   - Gestational Age 
PP                                -           Post Partum 
ICF                             -            Intra Cellular Fluid 
ECF                            -            Extra Cellular Fluid. 
  
 
 
 
 
 
 
 
 
 
INTRODUCTION 
  
                                           INTRODUCTION 
Gestational  diabetes  mellitus  ( GDM )  is  a  metabolic  disorder  in  
pregnancy.  It  is  defined  as  glucose  intolerance  that  begins  or  is  first  
recognized  during  pregnancy.  Its  prevalence  varies  from  4.6%  to  9.2%  
around  the  world  (CDC 2014).  Moreover  it  was  more  prevalent  in  urban  
areas.  GDM    not  only  a  risk  factor  for  adverse  perinatal  outcome    also  for  
the  development  of  type  2  diabetes  mellitus. 
          The  exact  cause  for  GDM  is  not  clearly  known.  It  is  characterized  
by  insulin  resistance  and / or  decreased  insulin  secretion.  There  are  several  
predisposing  factors  for  diabetes  such  as  age,  ethnicity,  obesity,  family  
history  of  diabetes.  GDM  is  usually  starts  in  middle  and  late  gestational  
period  and  continues  to  term.  Impaired  glucose  tolerance  is  more  critical  
especially  at  the  beginning  of  the  second  trimester  of  pregnancy 
1
.
 
             
     Normal  pregnancy  is  a  state  of  insulin  resistance.  Many  maternal   
hormones  and  factors  play  a  role  in  causation  of  insulin  resistance  during  
pregnancy.  In  healthy  pregnant  women  insulin  resistance  is  compensated  by  
pancrease,  but  in  GDM  women  there  is  a  impaired  beta  cell  function.  
Insulin  resistance  during  pregnancy  due  to  alteration  in  the  hormonal  level  
such  as  growth  hormone,  cortisol,  human  placental  lactogen  and  insulinase  
secretion.  During  pregnancy  the  imbalance  between  insulin  resistance  and  
secretion may  lead  to  hyperglycemia.  Undesirable  effects  of  hyperglycemia  
1 
and  GDM  include   premature  delivery,  dystocia,  macrosomia,  neonatal  
hypoglycemia  etc 
2
.
 
                             
  There  are  many  evidences  on  association  between  hyperglycemia  and  
metabolism  of  minerals.  Though  macro  elements  are  important  nutrients  for  
the  body,  trace  elements  also  perform  an  essential  role  in  various  metabolic  
processes.  Adequate  maternal  nutrition  before  and  during  pregnancy  is  
imperative  to  the  health  of  both  mother  and  child.  The  metabolism  of  
several  minerals  has  been  reported  to  alter  in  diabetes  mellitus  and  these  
elements  might  have  specific  role  in  the  pathogenesis  and  progress  of  the  
disease.  Among  these  Zinc  and  Magnesium  are  essential  trace  elements  
with  wide  range  of  functions  in  the  body.  They  are  important  for  the  
growth  and  biological  functions.  They  act  as  a  cofactors  for  many  
metabolic  reactions  and  play a  vital  role  in  basic  cellular  reactions  required  
to  maintain  energy  production  and  life.    
 
  Zinc  an  essential  trace  element  is  useful  in  the  synthesis, storage,  and  
secretion  of  insulin.   Zinc  as  a  trace  element  has  indispensible  role  in  
human  health  and  diseases.    Zinc  is  found  as  component  of  more  than  300   
enzymes  and  plays  a  vital  role  in  the  maintenance  of  immune  functions,  
many  fundamental  activities  of  cellular  metabolism,  taste  sensation.  Function  
of  zinc  can  be  categorised  into  catalytic,  structural,  and  regulatory. Zinc  
deficiency  affects  about  2.2  billion  people  around  the  world.  As  biosystems  
2 
are  unable  to  store  zinc,   regular  intake  is  necessary  .  Zinc  deficiency  can  
be  acute  (diet  poor  in  zinc),  or  chronic  (inadequate  absorption) 
3
. 
 In  the  mammalian  pancreatic  beat  cell,  zinc  is  essential  for  
processing ,  storage,  secretion  and  action  of  insulin.  Insulin  is  stored  in  the  
secretory  vesicles  or  granules,  where  two  ions  of  zinc  combines  with  six  
monomers  of  insulin  and  form  hexameric  structure  of  insulin.  Changes  in  
zinc  levels  in  pancrease  have  been  found  to  be  associated  with  diabetes.  
Crystallographic  studies  have  demonstrated  the  presence  of  zinc  in  crystals  
of  insulin  confirming  the  close  relationship  between  zinc  and  insulin 
1
. 
     The  name  magnesium  originate  from  Greek  word  -  magnesia.  The  
important  interaction  between  phosphate  and  magnesium  makes  magnesium  
essential  to  the  basic   nucleic  acid  chemistry  of  all  cells.  Serum  levels  are  
typically  1.8 - 2.4 meq / L.  Serum  magnesium  levels  may  be  normal  even  
when  intracellular  magnesium  is  deficient.  Low  plasma  magnesium  is  
common,  the  primary  cause  of  deficiency  is  low  dietary  intake.  Magnesium  
has  an  important  role  in  insulin  action,  and  insulin  stimulates  magnesium  
uptake 
3
 . 
 Plasma  and   intracellular  magnesium  concentrations  are    regulated  by  
insulin  and  other  factors.  Lower  intracellular  magnesium  concentration    may  
result  in  a  defective  tyrosine  kinase  activity  at  the  insulin  receptor  level  
and  increase  the  intracellular  calcium  concentration.  This  will  result  in  
impairment  of  insulin  action and  a  worsening  of  insulin  resistance.  Meta  
3 
analysis  of  thirteen  prospective   cohart  studies  involving  536318  participants  
detected  a  significant  inverse  association   between  magnesium  intake  and  
risk  of  type 2 diabetes  mellitus.  Of  536318  participants  24516  cases  of  DM  
were  detected 
4
 .  Since  magnesium  is  an  intracellular  cation,  it  is  very  
difficult  to  measure  without  invasive  techniques.  Serum  magnesium  levels  
can  be  measured  but  it  does  not  necessarily  reflect  the  more  important  
intracellular  concentration.  Although  magnesium  deficiency  is  often  reflected  
by  low  serum  concentration  deficiency  often  exists  even  with  normal  serum  
levels. 
 
 In  developing  countries  where  diet  is  monotonous  and  deficient  in  
trace  elements pregnant  women  are  at  increased  risk  of  magnesium  and  zinc  
deficiencies.  This  is  aggravated  by  increased  demand  for  these  trace  
elements  to  meet  both  the  maternal  and  foetal  needs.  Some  studies  have  
shown  that  micronutrient  deficiency  is  one  of  the  serious  issues  in  
gestational  diabetes  mellitus.  Other  studies  have  shown  that  no  deficiency  
of  zinc,  magnesium  level  in  gestational  diabetes  women.  The  aim  of  the  
present  study  is  to  determine  the  serum   levels  of  zinc,  magnesium  in  
GDM  primi  and  to  compare  with  normal  pregnant  women. 
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AIMS AND OBJECTIVES 
 
 
 
 
 
 
 
 
 
  
 
 
   
 
AIM: 
 To  compare  the  serum  micronutient  (  zinc,  magnesium )  concentration  
in    primigravida  with  gestational  diabetes  mellitus  and  normo  glycemic    
primigravida. 
 
OBJECTIVES: 
 To  estimate  the  serum  magnesium  and  zinc  levels  in  primigravida  
women    with   gestational  diabetes  mellitus. 
 To  estimate  the  levels  of  serum  zinc,  magnesium  in  normal  primi  
women. 
 To  compare  the  concentrations  of  zinc  and  magnesium  between  
women  diagnosed  with  GDM  and  normal  primigravida. 
 To find correlation between blood sugar levels and serum zinc, magnesium 
concentrations in GDM. 
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REVIEW OF LITERATURE 
 
 
 
  
REVIEW OF LITERATURE 
INSULIN 
INTRODUCTION: 
 Insulin  hormone  is  a  51  residue  anabolic  protein,  plays  a  important  
role  in  regulation  of  metabolism.  It  is  secreted  by  beta  cells  of  islets  of  
langerhans  of  pancreas.  In  1916  Schafer  first  speculated  that  an  Antidiabetic  
hormone,  which  he  named  insuline. 
STRUCTURE : 
 
Insulin  was  the  first  peptide  hormone  discovered.  Sequence  of  human  
insulin  is  identical  to  that  of  porcine  insulin  except  Ala  B30  to  Thr30  in  
human  insulin.  Primary  sequence  of  insulin  as  determined  by  Sanger,  
insulin  was  a  two  chain  heterodimer  consisting  of  a  21  residue  A  chain  
linked  to  a  30  residue  B  chain  by  two  disulfide  bonds
1
. 
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BIO SYNTHESIS: 
In   humans,  the  short  arm  of  chromosome  11  contains  the  gene  for  
preproinsulin,  which  is  the  precursor  of  insulin.  Its coding  region  consists  of 
3 exons,  Transcription and  splicing  to  remove  the  sequences encoded  by  
introns  yields   a   messenger  RNA  of  600  Neucleotide,    transulation   of  
which  gives  rise  to  preproinsulin.  Preproinsulin  is  rapidly  discharged  into  
cisternal space  of  rough   endoplasmic   reticulum,  where  proteolytic  enzymes  
immediately  clear the  single  peptide,  generating  proinsulin. 
  
   The  structural  conformations  of  proinsulin  &  insulin  are  very  similar 
and  a  major  function   of  the   c- peptide   is   to   align   the   disulfide   bridges   
that   link  the  A & B  chains  so  that  the  molecule  is  correctly  bolded  for  
cleavage.   Proinsulin  is transported  in  microvesicle  to  the  golgi  apparatus,  
where  it  is  packaged  into  membrane – bound  vesicles  known  as  secretary  
granules.   The  conversion  of  proinsulin to  insulin  is  initiated  in  Golgi  
Complex  and   continues   within  the   maturing   secretary  granule   through   
the   sequential  action   of   a   endopeptidases  ( Prohormone  convertase 2 & 3)   
and  carboxypeptidase H,  which   remove   the   C- peptide   chain,   liberating   
two cleavage  dipeptides  and  finally  yielding  insulin. 
  
Insulin  and  C-peptide  are  stored  together  in  the  secretary  granules  
and  are ultimately   released   in   equimolar   amounts   by  a   process   of   
regulated   exocytosis.  Under  normal   conditions  > 95 %   of   secreted   product  
7 
is  insulin  &  < 5 %   release   as proinsulin. However  secretion  of  incompletely  
processed  insulin  precursors  is  increased  in  some patients  with  type  2   
diabetes. 
  
          β cell  responds  to  increases  in  the  circulating  concentrations  of  
nutrients  by increasing  insulin  production  and  secretion,  thus maintaining  
insulin  stores.  Acute (<2 hours)  increase  in  Extracellular  concentration  of 
glucose  &  other  nutrients  result  in  a  rapid  and  dramatic  increase  in  the  
transcription  of preproinsulin  mRNA  and  in  the  rate  of  proinsulin  synthesis.  
There  is  a  sigmoidal relationship  between  glucose  concentration &  bio  
synthetic  Activity,  with  a  threshold  glucose  level  of  2 to 4  mmol / L.  This   
is  slightly  lower  than  the  threshold  for  the stimulation  of  insulin  secretion  
which  ensures   an   adequate   reserve   of   insulin   within  the   β cell 1. 
 
INSULIN STORAGE: 
 
8 
 Insulin  becomes  associated  with  zinc  as  the  secretory  granules  
mature.  Newly  synthesised  insulin  likely  to  form  crystals  with  zinc  that  are  
transported  into  mature  secretory  granule.  In  the  presence  of  zinc,  insulin  
dimers  associate  to  form  hexameric  units  co-ordinated  by  2  zn  ions  within  
central  axis  of  hexamer.  The  zinc  -  insulin  crystals  form  the  dense  central  
core  of  the  granules,  whereas  C- peptide  is  present  in  the  clean  space  
between  granule  membrane  and  core.  The  insulin  secretary  granule  has a 
typical appearance in electron micrographs, with a wide space between the 
crystalline electron – opaque core and its limiting membrane. The major protein 
constituents of the granules  are  insulin and  C- peptide. 
  
 Microtubules are formed by the polymerization of  tubulin subunits and 
normally form a network radiating outwards from the perinuclear region. The 
microtubular network is in a process of continual remodeling and the dynamic 
turnover of tubulin rather than the total number of microtubules is important for 
the mechanism of secretor . The microtubule framework may provide  the 
pathway for the secretory granules but microtubules do not provide the motive 
force. So other contractile proteins are likely to be involved. Actin is the 
constituent protein of microfilaments which exist in cells as a globular form and 
as a filamentous form which associates to form microfilaments. 
 
 Microfilament Polymerization is regulated by agents that alter rates of 
insulin secretion and the pharmacologic disruption of microfilament formation 
9 
inhibits insulin secretion. myosin light and heavy chains are expressed at high 
concentrations in β cells, suggesting that acting & myosin may interact to propel 
granules along the micro tubular network.  It also seems likely that other 
molecular motors,  including  kinesin  &  dynein  are also  involved  in  movement 
of  secretory  granules & perhaps  other  organells  in  β  cells.  
 Insulin is released from secretory granules by exocytosis, a process in 
which the granule membrane and plasma membrane fuse together, releasing the 
granule  contents into the interstitial space. Much of knowledge  of the molecular 
mechanisms of exocytosis is derived from studies of Neurotransmitter   release 
from nerve cells, and similar mechanism operate in β cells 1. 
 
SECRETION: 
 
Blood  glucose  is  the  major  stimulant  for  insulin  secretion.  Secretion  
of  insulin  is  not  only  an  important  step  in  regulation  of  glucose  
homeostasis  in  healthy  individuals  but  has  also  been  demonstrated  to  be  
impaired  in  both  type 1  and  type 2  diabetes  mellitus.  Only  a  small  portion  
10 
of  insulin  stored  in  vesicles  released,  even  under  maximum  stimulation,  this  
suggests  that  insulin  levels  are  regulated  by  secretion  rather  than  by  
synthesis  and  is  not  ordinarily  limited  by  size  of  storage  pools
1
 . 
EFFECT  OF  INSULIN: 
Insulin  receptor  is  a  protein  kinase  receptor  that  contains  enzyme  
activity.  Once  insulin  arrives  at  the  target  cell,  it  binds  with  the  insulin  
receptor  ( alpha  chain)  activates  tyrosine  kinase  activity  of  the  beta  chains.  
The  IRS  tyrosine  phosphorylations  are  followed  by  various  cascades  of  
events  that  ultimately  produce  gene  expression,  Translocation  of  glucose  
transport  proteins  to  the  plasma  membrane,  activation  or  deactivation  of  
numerous  enzymes  in  glucose  and  fatty  acid  metabolism  and  protein  
synthesis. 
             
  Insulin  increases  uptake  of  glucose  in  target  cells  ( muscles,  adipose  
tissue,  leucocyte,  mammary  gland)  by  translocating  the  glucose  transporter  
into  the  cell  membrane.  Tissues  in  which  glucose  transport  is  not  insulin  
dependent  include  nervous  system,  kidney,  RBC,  retina,  blood  vessels,  and  
intestinal  mucosa 
1
. 
 
DIABETES 
 The  prevalence  of  diagnosed  diabetes  among  American  adults  has  
increased  by 40%  in 10 years  &  rose from 4.9%  in 1990 to 6.9%  in 1999.  
11 
More worryingly,  it is estimated  that  this incidence will increase another 165% 
by 2050, to put this into perspective  the  lifetime  Risk of diabetes  in  individuals  
born  in  2000  is  33%  for  males & 39%  for females 
2 
. 
 
Increasing prevalence of type 2 Diabetes particularly in younger people in 
particular has led to an increasing number of pregnancies with  complications.  
Many women found to have gestational diabetes are likely to have type 2 Diabetes 
that has previously gone undiagnosed.  Indeed  the  incidence of  Diabetes  
complicating   pregnancy has increased  approximately 40%  between  1989  and  
2004.  There is keen interest in events that precede diabetes and this includes the 
mini – environment of uterus,  where it is believed that early imprinting can have 
effects later in life. For example,   In utero exposure to maternal hyperglycemia 
leads to fetal hyperinsulinemia, causing an increase in fetal fat cells  which leads 
to obesity and insulin resistance in childhood. This in turn leads to impaired 
glucose intolerance & diabetes in adulthood. Thus a cycle of fetal exposure to 
diabetes  leading  to  childhood  obesity  & glucose intolerance is set in motion. 
This sequence   has  been   reported  in  pima Indians as well as a heterogenous 
Chicago population 
2
. 
 
CLASSIFICATION 
 Diabetes is now classified based on the pathogenic processes involved. 
Absolute insulin deficiency characterizes type I diabetes,  whereas  defective 
insulin secretion or insulin  resistance  characterizes  type 2  Diabetes.  The terms 
12 
IDDM & NIDDM are no longer  used. Age is also no longer used in classification  
because pancreatic β cell disfunction  can  begin  at  any  age.  Most  commonly  
its  onset  is  before   age  30  but  in 5 to 10%  of  affected  individuals,  onset  is  
after  age  of 30 years. Type 2 diabetes, although  most  typical  with  increasing  
age  also develops   in  obese  adolescents 
2
. 
CLASSIFICATION  DURING  PREGNANCY 
 Diabetes  is  the  most  common  medical  complication  of  pregnancy .  
Women can be  separated  into  those who were known to have diabetes before 
pregnancy -- Pregestational  or  overt  and  those  diagnosed  diabetes  during  
pregnancy  are gestational.  In 2006, Slightly  more  than 1,79,898  American  
women  had  pregnancies  complicated  by some form of diabetes, representing 
4.2% of all live births. In the United States, African – Americans, Native 
Americans, Asians and Hispanic women are at higher risk for gestational diabetes 
compared with white women. The   incidence of Gestational Diabetes  over the 
past 15 years  was  increased 
2
. 
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ETIOLOGICAL  CLASSIFICATION  OF  DIABETES  MELLITUS 
1. Type 1 
 β cell  destruction,  usually  absolute  insulin deficiency  
                          A  -  Immune mediated                                                                                                                 
                          B  -  Idiopathic 
2. Type 2 
 Ranges  from  predominantly Insulin Resistance to predominantly an 
Insulin          Secretory  defect  with  Insulin – Resistance . 
3. Other types 
 A –  Genetic  mutation  of  β cell  function 
 B –  Genetic  defects  in  insulin  action 
 C – Genetic syndromes  ( Down,  Klinefelter, Turner ) 
 D –  Disease  of  exocrine  pancreas  (Pancreatitis / Cystic.Fibrosis) 
 E  –  Endocrinopathies   (  cushing syndrome,  pheochromocytoma ) 
 F – Drug or chemical induced   (Glucocorticosteroid/ Thiazides / β          
                 adrenergic agonist). 
 G –  Infection   (Congenital  Rubella, CMV, Coxsackie Virus). 
4. GDM. 
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GESTATIONAL DIABETES 
   Carbohydrate  intolerance  of  variable  severity  with onset or first  
recognition  during  pregnancy  is  known  as  gestational  diabetes  mellitus.  This 
definition applies whether  or  not  insulin  is  used for treatment. Undoubtedly 
Some women with gestational diabetes have previously unrecognized  overt  
diabetes.  Sheffield  and  co- workers studied outcomes in 1190   diabetic  women 
delivered at parkland hospital between 1991 and 1995.  They  found  that women 
with fasting hyperglycemia diagnosed before 24weeks had pregnancy outcomes 
similar to those for women overt diabetes. Bartha & most with their colleagues 
reported similar results. Thus, fasting  hyperglycemia early  in  pregnancy  almost 
invariably represents  overt  diabetes 
2
. 
 
SCREENING 
 Despite  more than 40 yrs of  Research,  there  is  no consensus  regarding  
the optimal  approach to screening  for  Gestational  Diabetes. The  major  issues  
include whether  universal  or selective screening should be used  and  which  
plasma  glucose  level after  a  50 – g  glucose  test  threshold   is  best  to  identify  
women  at  risk  for  GDM. 
  
 Screening  should  be  performed  between 24 and 28 weeks  in  those  
women  not  known  to  have  glucose  intolerance  earlier  in pregnancy.  This 
evaluation is usually done in 2 steps.  In the 2 step  procedure,  a 50g – oral 
15 
glucose challenge test is followed by a diagnostic 100g OGTT, if initial results 
exceed a predetermined plasma glucose concentration.  
 
 Plasma  glucose  level  is  measured  one  hour  after  a  50 g  glucose  load  
without regard  to  the  time  of  day  or   time  of   last  meal.   A  value  of   > 140 
mg / dl   identifies 80%   of  all  women  with  Gestational  Diabetes  using  a  
value  of   > 130 mg / dl   increase  the yield  to  greater  than  90%.   However  20 
–  25%   of  women  will  have  false  positive test  results  compared  with  only  
14 to 18%   when  the   >  140    cut of value  is  used. 
  
 The  day – to day  reproducibility  of  the  50 g – screening  test  has  been  
evaluated by Espinosa de los Monteros  and  Co – workers.  Although    90% of  
normal  results  were reproducible  the  next  day,  only  83%   of  abnormal  test  
results  were  reproducible. Murphy &  colleagues studied the accuracy & 
Precision of Reflectance Photometers. Accucheck III –  for  Screening  because  
this  required  redefining  the  circumstances  for Testing &  threshold  values  for  
abnormal  results,  it  seem  best  to  avoid  these devices  for  screening.  Gabbe &  
associates surveyed  practicing  OG in 2003 &   reported  that  96% used  
universal  screening  for  Gestational  diabetes.  Integral  to Justifying  this  
practice  is the  requirement  to  show  that  women  who  screen  positive  are  
benefited  by  the treatment
 2
. 
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MATERNAL  &  FETAL  EFFECTS  
  Adverse fetal consequences of   diabetes  varies  in women with 
gestational  diabetes  than  in  women  with  overt diabetes, fetal anomalies are not 
increased. Similarly,  pregnancies  in  women  with  overt  diabetes  are at  greater  
risk  for fetal death. This danger is not apparent for those who have diet – treated 
post prandial hyperglycemia.  
 
 In contrast, women with elevated fasting glucose levels have  increased 
rates of unexplained still births similar to women with pre gestational diabetes 
specifically the American  Diabetes  association  has  concluded  that  fasting  
hyperglycemia   >  105   mg/dl may  be associated with  an  increased  risk  of  
fetal  death  during  the  last  4 – 8  weeks  of gestation. Adverse maternal effects 
include an increased frequency of hypertension & cesarean delivery 
2
. 
 
MANAGEMENT 
 Women  with  gestational  diabetes  can  be  divided  into  2   functional   
classes using  fasting  glucose  levels.  Insulin  therapy  is  usually  recommended  
when  standard dietary  management  does  not  consistently   maintain  the  
fasting  plasma  glucose   at   < 95 mg / dl  or  2 hr  Postprandial  plasma  glucose  
< 120   mg/ dl.   Whether   insulin  should be  used  in  women  with   lesser  
degree  of  fasting   hyperglycemia – 105 mg/dl   or   less before  dietary  
intervention  is  unclear  because  there  have  been  no  controlled  trials  to 
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identify  ideal  glycemia  targets  for prevention of fetal risks.  The  fifth  
international workshop  conference on  GDM,  however  recommended  that  
maternal  capillary  glucose levels  be  kept   <  95mg/dl   in  the  fasting  state 
2
. 
 
DIET  
 ADA  has  recommended  nutritional  counseling  with  individualization  
based  on height  &  weight  and  diet  that  provides  an  average  of  30 kcal / kg / 
day   based  on pregnant  bodyweight  for  non-obese  women.  Although  the  
most  appropriate  diet  for women  with  GDM   has  not  been  established,  the  
ADA  has  suggested  that  obese women  with  a  BMI  > 30 kg / m
2
   may  
benefit  from  30%   caloric  restriction  and should  be  monitored  with  weekly  
tests  for  ketonuria,  because  maternal  ketonemia,  has been  linked  with  
impaired  psychomotor  development  in  offspring.  Langer   & colleagues  found  
that   insulin  was  necessary   to  achieve  glucose  control  in  obese women 
2
. 
 
EXERCISE 
 Because  exercise  is  known  to  be  important  in  non- pregnant  Patients,  
the American  college  of  O & G   reviewed  3  Randomized  Trials  of  exercise  
in  women  with  GDM.  The  results  suggested  that  exercise  improved  cardio  
respiratory  fitness without  improving  pregnancy  outcome.  Dempsey   &  
coworkers  found  that  physical activity  during  pregnancy  reduced  the  risk  of  
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gestational  diabetes.  Brankston & associates  reported  that  resistance  exercise  
diminished  the  need  for  insulin  therapy  in overweight  women  with  GDM 
2
. 
 
GLUCOSE  MONITORING  
 Hawkins & colleagues  compared  outcomes  in  315  women  with  diet –  
treated gestational  diabetes  who  used  personal  glucose  monitors  with  those  
of  615  women  with  GDM   who  were  also  diet - treated  but  who  underwent   
glucose  evaluation intermittently  during  obstetrical   visits only.  Women  using  
daily  self-blood  glucose  monitoring  had  fewer  macrosomic  infants & gained  
less  weight  after  diagnosis-  median  0.56  compared  with  0.74  pounds  per  
week – then  women  evaluated  during  clinic  visits only.  These  researcher’s  
findings  support  the  common  practice  of  self  blood  glucose monitors  for  
women  with  GDM   who  are  treated  with  diet  alone. 
                 
  Postprandial  surveillance  for  GDM  has been  shown  to  be  superior  to  
pre-prandial   surveillance.  Devecians & colleagues  studied  66  pregnant  
women  with Class  A2  diabetes  in  whom  insulin  was  initiated  for  fasting  
hyperglycemia.  The women  were  randomized  to  glucose  surveillance  Using  
either  pre-prandial  or  1  hour Postprandial  capillary  blood  glucose  
concentration   measured by glucometer.  Postprandial  surveillance  was  shown  
to  be  superior  in  that  blood  glucose  control  was  significantly improved  &  
was  associated  with  fewer  causes  of   neonatal  Hypoglycemia  3  versus 21%  
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less  macrosomia  12  versus  42 %  &  fewer  cesarean  deliveries for  dystocia  
24 versus  39% 
2
. 
 
INSULIN 
 Insulin  given  to  decrease  the  complications  related  to  macrosomia  in  
women with  GDM  & fasting  euglycemia  has  long  been  controversial.  Langer 
& co -workers reviewed  23  reports  from  1979  through  1993  &  found  that  
none  demonstrated improved  prenatal  outcomes  related  to  any  management  
approach, including prophylactic  insulin  treatment.  Four  Randomized  studies  
reported  between  1989  & 2001  showed  that  intensive  therapy  had  little  
effect  on  birthweight,  birth Trauma, operative  delivery  or  neonatal  
complications. 
 
 Most  practitioners -  93 %  According  to  Owen  &  colleagues  initiate  
insulin therapy  in  women  with  GDM  if  fasting  glucose  level  exceeding  105 
mg/ dl  persist despite  diet  therapy.  A  total  dose  of  20 – 30  unites  given  
once  daily  before  breakfast is  commonly  used  to  initiate  therapy.  The  total  
dose  is  usually  divided  into  2/3 intermediate  acting  insulin  &  a  third  short  
acting  insulin.  Alternatively,  weight  based split  dose  insulin  is   administered  
twice  daily.  Once  therapy  has  been  initiated,  it  must  be  recognized  that  the  
level  of  glycemic  control  to   reduce  fetal   &  neonatal complications  has  not  
been  established 
2
.  
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OHA:   (Oral  Hypoglycemic  Agent ) 
 The  American  College  of  O & G  has  not  recommended  these  agents  
during pregnancy.  Langer & Colleagues  randomized  404  women  with  GDM   
to  insulin  versus glyburide  therapy.  Near  normoglycemia  levels  were  
achieved  equally  well   with either regimen  and  there  were  no  apparent  
neonatal  complications  attributable  to  glyburide.  In  a  follow-up  study  
Conway & co-workers  reported  that  women   with  fasting   glucose levels  > 
110 mg/dl  did  not  adequately  respond  to  glyburide  therapy.  Similar  results 
were  reported  by  Chmait & Kahn  and  their associates. Until  recently,  
glyburide  was thought  not  to  cross  the  placenta,  Hebert & colleagues,  
howeller  sampled  20  paired maternal  &  umblical  specimens and  found  
umblical  cord   concentrations  were  half  that of  maternal  concentration  in  
women  treated  with  glyburide. 
  
 There  is  increasing  support  for  the  use  of  glyburide  as  an  alternative  
to  insulin in  the  management  of  gestational  diabetes.  A  survey  of  almost  
1400  fellows  of American  college  of  O & G  found  that  13 %  of  respondents  
were  using  glyburide  as 1
st
   line therapy  for  diet  failure  with  GDM.  Further  
evidence  of  expanding  use  of glyburide  was  provided  by  Kremer & Jacobson 
and  their colleagues.  They   reported    glyburide  as  an  alternative  to  insulin  .  
Most  of  these  women  required  daily  glyburide doses  < 7.5 mg  to  achieve  
glucose  control.  Hypoglycemia  was  reported  to  be  less frequent  when  
glyburide  was  compared  with  insulin.  In  a  recent  meta – Analysis, moretti & 
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Associates  reported  no  increased  perinatal  risks  with  gluburide  therapy  and   
recommended  further  randomized  trials. 
 Metformin  has  been  used  as  treatment   for  polycystic Ovarian Disease  
and  has been  reported  to  reduce  the  incidence  of  GDM  in  women  who  use  
the  drug  througout pregnancy.    The  5
th
 international  workshop  conference  
recommended  that  metformin   treatment  for  GDM  be  limited  to  clinical  
Trials  with  long  term  infant  follow –up 2. 
 
OBSTETRICAL   MANAGEMENT 
 In  general  women  with  GDM   who  do  not  require  insulin  seldom  
require  early delivery  or  other  interventions.  Elective  cesarean  delivery  to  
avoid  brachial   plexus injuries  in  macrosomic  infants  is  an  important   issue.  
American  college  of  O & G  has suggested  that  cesarean  delivery  should  be  
considered  in  women  with  a sonographically  estimated  Fetal  weight  > 4500g.  
Effects  of  such  a  policy  were retrospectively  analysed  by  Gonen & 
Colleagues  in  a  general  obstetrical  population  of >16000  women.  Elective  
ceasaren  delivery  has  no  significant  effect  on  incidence  of brachial  plexus   
injures. 
  
 Elective  induction  to  prevent  shoulder  dystocia  in  women  with   
sonographically diagnosed  fetal  macrosomia  compared  with  spontaneous  
labour  is  also  controversial. Conway   &  Langer  found  that  elective  delivery  
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reduced   the  rate  of  shoulder  dystocia from  2.2 to 0.7%.   In  constrast,  
charhan  &  co-workers  reviewed  the  literature  and concluded  that  
sonographic  suspicion  of  macrosomia  was  too  inaccurate  to  recommend 
induction   or  primary  cesarean  delivery  without  a  trial  of  labour.  There  is  
no  consensus  regarding  whether  antepartum  fetal  testing  is  necessary and  if  
so,  when  to  begin  such  testing  in  women  without  severe  Hyperglycemia 
2
. 
 
POST PARTUM EVALUATION 
           The  5
th
  International  workshop  conference  on  gestational  diabetes 
recommended  that  women  diagnosed  with  gestational  diabetes  undergo  
evaluation  with a  75g  oral  glucose  tolerance  test  at  6- 12  weeks  postpartum  
&  other  intervals thereafter.   Although  Postpartum  follow –up  of  women  
diagnosed  with  GDM  was recommended  for  PP  follow up  are  based,  on  the  
50 %  likelihood  of  women  with GDM   developing  overt  diabetes  within  20 
years.  If  there  is  fasting  Hyperglycemia    then  Diabetes  is  more  likely  to  
persist  postpartum.  For  Example  in  women  with  fasting  glucose  levels  of  
105  to  130  mg/d1,  43 %  were  found  to  be overtly  diabetic,  when  fasting  
glucose   exceeded 130mg/dl  during  pregnancy,  86 % became  overtly   
diabetics. 
 
 Likewise  insulin  therapy  during  pregnancy  and  especially  before  24  
weeks  is  a powerful  predictor  of  persistent  diabetes.  Women  with  a  history  
of  gestational  diabetes are  also  at  risk  for  cardiovascular  complications  
23 
associated  with  dyslipidemia, hypertension  and  abdominal  Obesity –  the  
metabolic  syndrome.  Pallardo  and  colleagues evaluated  cardiovascular  disease  
risk factors  3-6 months  PP  in  788  women  with   GDM. They  found  that  the  
degree  of  PP  Glucose   inloterance  was  significantly  associated with  these  
risk  factor.  A  recent  Canadian  study  by  Shah  &  coworkers   documented 
excessive  cardiovascular  disease  even by  10 years  in  these  women  compared  
with  non-diabetic  controls.  Finally  Akinci  &  Associated  reported  that  a  
Fasting  glucose  level   ≥ 100mg/dl  with   index  OGTT   was  an  independent  
predictior  of  metabolic  syndrome. 
 
 Recurrence  of  GDM  in  subsequent   pregnancies   was   documented   in   
40%   of 344  primiparous  women  analysed  by  Holmes  and  colleagues.  Obese  
women  were   more  likely  to have  impaired  glucose  intolerance  in  subsequent  
pregnancies.  Thus lifestyle  behavioural  changes  including  weight  control  and  
exercise  between  pregnancies   likely  would  prevent  recurrence  of  GDM   as  
well  as  modify  onset  and severity  of  type  2  DM  later  in  life.  Interestingly  
perinatal   outcome  in  women  with previous  GDM   but  with  normal   glucose  
tolerance  test  during  a   subsequent  pregnancy  were  not  improved    with   
regard  to  birth weight / macrosomia,  route  of delivery  and  neonatal  
complication.  Finally  women   without   GDM   in   their  first  pregnancy   were  
unlikely  to  have  GDM   when  screened  in  a  2
nd 
pregnancy 
2
. 
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 ZINC RICH FOOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ZINC : 
Total  zinc  content  of  body  is  about  2 g  out  of  which  60 %  in  
Skeletal   muscle and  30 % in  bones.  Zinc  is  mainly  an  intracellular  element.  
Highest  concentration  of  zinc  is  seen  in  hippocampus  area  of  brain  and  
prostatic  secretion.  
 
HISTORY: 
In  1974,  NAS  (  National  Academy  of  Sciences) declared  zinc  to  be  
an  essential  element  for  humans  and  established  a  recommended  daily  
allowance. 
In  1978,  FDA  (  Food  &  Drug  Administration )  required  zinc  to  be  
in  total  parenteral  nutrition  fluids. 
 
In  2002  ZIP4  (  Zinc  Transporter )  was  first  identified  as  the  
mechanism  for  absorption  of  zinc  in  the  gut  across  the  basolateral  
membrane  of  enterocyte.  Zinc  may  have  an  effect  on  cancer  and  further  
study  is  recommended. 
 
SOURCES: 
Rich  dietary  sources  are  grain,  beans,  nuts,  cheese,  meat,  shellfish,  
egg,  and  milk.   
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ABSORPTION: 
Zinc  is  absorbed  mainly  in  duodenum.  Zinc  from  the  animal  sources  
is  better  absorbed  than  the  vegetable  sources.  Zinc  absorption  appears  to  be  
dependent  on  a  transport  protein  metallothionein.   
 
METALLOTHIONEIN: 
It  is  a  cysteine  rich,  low  molecular  weight  protein.  It  was  discovered  
in  1957  by  vallee  &  margoshe.  It  has  four  isoforms.  In  human,  large  
quantities  are  synthesised  primarily  in  the liver  &  kidney.  Production  is  
depend  on  availability  of  dietary  minerals  such  as  zinc,  copper,  selenium.  It  
is  involved  in  zinc  and  copper  regulation.  Metallothionein  participate  in  
uptake,  transport  and  regulation  of  zinc  in  biological  systems.  By  binding   
and  releasing  zinc,  metallothionein  may  regulate  zinc  levels  within  the  
body. 
 
Phytate,  calcium,  copper  and  iron  interfere  with  zinc  absorption,  
while  small  peptides  and  aminoacids  promotes  zinc  absorption.  Zinc  and  
copper   will  competitively  inhibit  each  other’s  absorption.  So  zinc  is  
therapeutically  useful   to   reduce   copper   absorption   in   wilson's   disease. 
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 In  liver,  zinc  is  stored  in  combination  with  a  specific  protein,  
metallothionein. zn  is  excreted  through  pancreatic  juice  and  to  a  lesser  
extent  through  sweat 
3
. 
 
SERUM  ZINC: 
 The  concentration  of  zinc  in  serum  is  about  100  mg / dl.  
Erythrocytes   contain  higher  content  of  zinc  about  1.5  mg / dl,  which  is  
found  in  association  with  the  enzyme  carbonic  anhydrase 
3 
. 
 
COLORIMETRIC  METHOD: 
For  the  determination  of  Zinc  in  serum  and  urine. 
Method  :  Nitro  -   PAPS  
Nitro  -  PAPS  is  a  highly  sensitive  colorimetric  reagent,  used  for  direct  
determination  of serum  iron  or  other  metals. 
CHEMICAL  NAME : 
                 2 - ( 5- Nitro - 2 - Pyridylazo ) - 5 - ( N - n - propyl - N - ( 3 - 
sulfopropyl ) Amino  phenol,  disodium  salt,  dihydrate. 
C17H19N5Na2O6S.2H2O. 
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PRINCIPLE: 
 Zinc  is  an  alkaline  medium  reacts with  Nitro-PAPS  to  form  a  purple  
coloured  complex.  Intensity  of  the  complex  formed  is  directly  proportional  
to  the  amount  of  zinc  present  in  the  sample. 
Zinc  +  Nitro  PAPS  ------  purple  coloured  complex. 
Normal  reference  value: 
Serum  :  60  -  120  µg / dl 
Urine  :  100  -  1000  µg / 24  hours. 
 
REQUIREMENTS : 
For  adult  -  10mg / day 
children     -  10mg / day 
 In  pregnancy  and  lactation  -  15 to 20 mg / day .   
Since  iron  inhibits  absorption  of  zinc, when  iron  is  supplemented,   zn  is  
also  to  be  given  to  prevent  zn  deficiency 
3
. 
BIOCHEMICAL  FUNCTION : 
1.  Zinc  is  an  essential  component  of  several  enzymes.  eg:  Carbonic 
anhydrase, alcohol dehydrogenase, alkaline phosphatase, carboxy peptidase, 
superoxide dismutase.  
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2.  Zinc  may  be  regarded  as  an  Antioxidant  since  the  enzyme  superoxide  
dismutase protects  the  body  against  free  radical  damage. 
3.  The  storage  and  secretion  of  insulin  from  the  Beta  cells  of  pancreas  
require  zinc. 
4.  Zinc  is  necessary  to  maintain  the  normal  level  of  vitamin A  in  
serum.  Zn promotes  the  synthesis  of  retinol  binding  protein. 
5.  It  is  required  for  wound  healing.  Zinc  enhances  cell  growth  and  
division,  besides stabilizing  biomembranes.  
6.  Gusten,  a  zn  containing  protein  of  the  saliva  is  important  for  taste  
sensation. 
7.  Zinc  is  essential  for  proper  reproduction 
3
. 
 
ZINC  DEFICIENCY  MANIFESTATIONS:  
 Zinc  deficiency  is  associated  with  growth  retardation,  poor  wound  
healing, Anemia,  loss  of  appetite,  loss  of  taste  sensation,  impaired  
spermatogenesis  etc. It  is  reported  that  Zn  deficiency  in  pregnant  animals  
causes  congenital malformations  of  the  fetus.  Deficiency  of  Zn   may  
result  in  depression, dementia  and  other  psychiatric  disorders.  The  
neuropsychiatric  manifestations  of chronic  alcoholism  may  be  partly  due  
to  zinc  deficiency. 
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                 Acrodermatitis  enteropathica  is  a  rare  inherited  metabolic  disease 
of  Zn         
       deficiency  caused  by  a  defect  in  the  absorption  of  zn  from  the  
intestine 
3
. 
 
ZINC TOXICITY : 
 Toxic  manifestation   are  seen  when  intake  is > 1000 mg / day.  Toxicity  
of  zn  is usually  seen  in  welders  due  to  inhalation  of  zinc  Oxide  fumes.  
Many  rat  poisons contain  zn  compounds  which  lead  to  accidental  poisoning. 
 
 Chronic  toxicity  may  produce  gastric ulcer,  pancreatitis,  Anemia,  
Nausea,  vomiting & Pulmonary fibrosis. Acute Toxicity is manifested as fever, 
excessive salivation, headache & Anemia 
3
. 
 
ZINC  AND  INSULIN: 
 Zinc  affects  insulin  signaling  pathway.  zinc  potentiates  the  mitogenic  
signaling  of  insulin,  and  activates  extra  cellular signal  regulated  kinases  1 & 
2.  Zinc  has  an  insulin  like  effect.  Coulston  &  Dandona  first  reported  that  
Zn  promoted  lipogenesis  of  rat  epididymal  adipocytes  through  a  post  insulin  
receptor  mechanism.  To  help  explain  the  results  of  transport,  the  
phosphorylation  state  of  several  proteins  in  the  insulin  signaling  pathway  
were  assayed.  First  the  effect  of  insulin  and  zinc  on  tyrosine  
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phosphorylation  of  95- K  Da  insulin  receptor  beta  subunit  were  investigated.  
Insulin  increases  tyrosine  phosphorylation  of  IR-B  subunit  on  both  3T3-L1,  
fibroblast  and  adipocytes.  Zncl2 also  produced  an  insulin  like  effect  but  
extent  was  lower  than  that  of  insulin 
5
.  Lowered  circulating  level  of  zinc  
are  also  found  in  diabetes  mellitus.  Zinc  ions  are  essential  for  a  huge  
range  of  cellular  funtions  and  in  specialised  pancreatic  beta  cell,  for  storage  
of  insulin  within  the  secretory  granule.    Studies  have  shown  that  zinc  may  
play  a role  in  improving  peripheral  insulin  sensitivity,  as  it  can potentiate  
insulin  stimulated  glucose  transport 
6
. 
           Genome  wide  association  studies  have  found,  the  islet-  restricted  zn  
transporter  zn T 8 ( SLC30A8 )  as  a  potential  controller  of  insulin  secretion  
and  hence  may  modulate  the  risks  of  developing  type 2 diabetes.  Results  
show  that  post  supplementary  HbA1c  values  were  significantly  reduced  in  
the  zinc  treated  groups  compared  with  controls 
7
. 
 
 It  appears  that  the  beneficial  effects  of  zinc  supplementation  on  
metabolic  parameters  can  be  seen  mainly  in  individuals  with  zinc  deficiency  
or  disease  causing  zinc  deficiency  such  as  diabetes.  In  addition  to  
hypoglycemic  and  lipid  lowering  effect  of  regular  zinc  supplementation  in  
patients  with  diabetes,  results  show  that  it  reduces  lipid  peroxidation  &  
hence  demonstrate  antioxidant  effects.  Thus  it  is  possible  to  hypothesis  that  
reduction  in  diabetes  complication  may  be  due  to  reduction  of  oxidative  
damage  from  zinc  supplementation
8
.  
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 MAGNESIUM RICH FOOD 
 
  
MAGNESIUM 
 The name  Magnesium  originates  from  the  greek  word  for  a  district  in  
thessaly  called  magnesia. 
 
 Magnesium  is  the   fourth  most  abundant  cation  in  the  body  and  2
nd
  
most prevalent  intracellular  cation.  Magnesium  is mainly  seen  in  intracellular 
fluid (ICF ). Total  body  mg  is  about  25g.  70 %  of  which  is  complexed  with   
Calcium  and  phosphorous  in  bone.  The  remaining  30 %   occurs  in  the  soft  
tissues  and  body  fluids. 1/3  of skeletal  mg  is  exchangeable  with  serum 
3
 . 
DIETARY  REQUIREMENTS : 
Adult  man  – 350 mg / day 
Adult  women – 300 mg / day 
 
SOURCES : 
Cereals/   nuts /  beans /  vegetables /  cabbage /  cauliflower / meat /  milk /  fruit. 
 
ABSORPTION : 
 Magnesium  is  absorbed  by  the  intestinal  cells  through  a  specific  
carrier  system.   About 50 %  of  the  dietary  mg  is  normally  absorbed.  
Consumption  of   large  amount  of calcium, phosphate and alcohol diminishes 
mg absorption. PTH (para thyroid hormone)  increases  mg  absorption. 
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NORMAL SERUM LEVEL OF MAGNESIUM : 
Normal  serum  level  mg  is  1.8-2.2  mg /dl.  Inside  the  RBC,  the  mg  
content  is   5 meq / l .  In  muscle  tissue  mg  is  20 meg / L  about  70%  of  mg  
exists  in  free  state  and  remaining  30%  in  Protein  bound (25%Albumin & 5% 
to globulin).  Serum  must  be separated  from  clot  as  soon  as  possible.  Or  the  
level  of  mg  will  increase  because  of its  elution  from  the   RBC.  Hemolyzed  
sample  as  well  as  blood  collected  with  citrate, oxalate  or  EDTA  are  
unacceptable  for  analysis.  Homeostasis  is  maintained  by  intestinal  absorption  
as  well  as  by  excretion by  kidney.  Mg  is  reabsorbed  from  loop  of  henle  
and  not  from  proximal  tubule 
3
. 
 
MODIFIED  XYLIDYL  BLUE  REACTION  METHOD: 
It  is  a  colorimetric  method  for  magnesium  estimation. 
 
PRINCIPLE: 
 Magnesium  determination  is  based  on  the  reaction  of  magnesium  
with  xylidyl  blue  1  ac  chelator  at  alkaline  pH  which   yields  a  purple  
coloured  complex. 
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FUNCTIONS 
1. Magnesium  is  the  activator  of  many  enzymes  requiring  ATP.  
Alkaline phosphatase / hexokinase /  Fundokinase,  PFK/   adenyl cyclase/  
cAMP dependent kinase, etc . 
2. Neuro muscular  irritability  is  lowered  by  magnesium. 
      3. Insulin  dependent  uptake of glucose is reduced in mg deficiency.  Mg 
supplementation  improves  glucose  tolerance 
3
 . 
 
DISEASE STATES : 
1.  Magnesium  deficiency  causes  neuromuscular  irritation,  weakness  and  
convulsion.  These symptoms  are  similar  to  that  observed  in  tetany (Ca 
deficiency)  which  are relieved  only  by  magnesium.  Malnutrition,  
alcoholism  and  cirrhosis  of  liver  may  lead  to  mg  deficiency. 
2.  Low  level  of  mg  may  be  observed  in  uremia,  rickets  &  abnormal  
pregnancy. 
 
HYPOMAGNESEMIA : 
 It  is  commonly  seen  in  hospital  patients.  Conditions  which  require  
magnesium estimation  are  enumerated  in  table.  When  serum  mg  level  falls  
below  1.7 mg /dl  it  is called  hypomagnesemia.  Vomiting /  Nasogastric 
suction,  diarrhoea,  liver  cirrhosis, protein – calorie  malnutrition  and  diuretic  
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therapy  are  the  common  causes.  Urinary loss can  occur  in  alcoholism,  
osmotic diuretics,  loop diuretics  and  Amino glycosides.  Serum mg  levels  need  
not  always  reflect  body  content.  measurement  of  urinary  mg  excretion will  
distinguish  between  renal  and  gastro  intestinal  losses. 
 
 Deficiency  of  magnesium  leads  to  Neuromuscular  hyperirritability  and  
cardiac arrhythmias.  The  mg  deficiency  symptoms  are  similar  to  those  of  
Ca  deficiency  but symptoms  will  be  relieved  only  when  mg  is  given.  Acute  
symptomatic  deficiency  is treated  by  giving  parenteral  mg.  Oral  therapy  may  
lead  to  diarrhoea  hence  i.v  mg sulphate  is  given 
3
. 
 
HYPERMAGNESEMIA : 
 It  is  uncommon  and  always  due  to  excessive  intake  either  orally 
(Antacids) rectally  (enema)  or  parenterally.  Magnesium  intoxication  causes  
depression  of  neuromuscular  system  causing  lethargy, hypotension,  
respiratory  depression,  bradycardia  and  weak  tendon  reflex.  In  severe 
conditions  acute  Rhabdomyolysis  results 
3
. 
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CAUSES :  
       
Hypomagnesemia Hypermagnesemia 
1. Urinary   loss (Tubular necrosis) 
2. Hyperaldosteronism 
    Volume expansion 
3. Familtral  hypomagensemia 
4. Increased  intestinal  loss  
    (Diarrhoea, laxatives, Ulcerative 
Colitis, 
    Nasogastric suction. 
5. Cirrhosis 
6. Malabsorption 
7. Protein  calorie  malnutrition 
8. Hypoparathyroidism 
9.Drugs:      
   Thiazide,Aminoglycoside,Cisplatin 
   Amphotericin,Cyclosporin, 
   Haloperidol , Alcohol. 
1.  Excess intake orally 
2.  RenalFailure 
3.  Hyperparathyroidism 
4. Oxalate poisoning 
5.  Rickets 
6.  Multiple myeloma 
7.  Dehydration 
8.  Drugs. 
 
Magnesium  is  one  of  the  most  abundant  ions  present  in  living cells  
and  its  plasma  concentration  is  remarkably  constant  in  healthy  subjects.  
Plasma   and  intracellular  magnesium  concentration  are  tightly  regulated  by  
several  factors.  Among  them  insulin  seems  to  be  one  of  the  most  
important.  In  vitro  &  in  vivo  studies  have  demonstrated  that  insulin  may  
modulate  the  shift  of  magnesium  from  extracellular  to  intracellular  space.  
Intracellular  magnesium  concentration  has  also  been  shown  to  be  effective  
in  modulating  insulin  action mainly  oxidative  glucose  metabolism.  A  poor  
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intracellular  magnesium  concentration  as  found  in  NIDDM  patients  may  
result  in  a  defective  tyrosine  kinase   activity  at  the  insulin  receptor  level  
and  is  responsible  for  the  impairment  in  insulin  action  and  a  worsening  of  
insulin  resistance  in  NIDDM.  By  contrast  in  NIDDM  patients  daily  
administration  of  magnesium  restoring  a  more  appropriate  intracellular  
magnesium  concentration  contributes  to  improve  insulin  mediated  glucose  
uptake.  The  benefits  deriving  from  daily  magnesium  supplementation  in  
NIDDM  patients  are  further  supported  by  epidemiological  studies  showing  
that  high  daily  magnesium  intake  are  predictive  of  a  lower  incidence  of  
NIDDM.  Intracellular  magnesium  may  play  a  key  role  in  modulating  
insulin  mediated  glucose  uptake 
9
. 
FUNCTION  OF  MAGNESIUM  IN  INSULIN  SECRETION 
 
Glucose  is  the  important  stimulator  of  insulin  secretion  from  pancreatic  beta  
cell.  The  first  step  in  insulin  secretion  is  their  intracellular  uptake  of  
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glucose  via  GLUT  2.  Glucose  is  metabolized  via  glycolytic  pathway,  
tricarboxylic acid  cycle,  oxidative  phosphorylation.  Numerous  enzymes  in  
these  metabolic  pathways  are  dependent  on  magnesium. 
 
FUNCTION  OF  MAGNESIUM  IN  INSULIN  SIGNAL  
TRANSDUCTION  
 The  binding  of  insulin  to  its  receptor  results  in  autophosphorylation  
and  internalization.  Internalized  insulin  receptors  phosphorylate  IRS  1 -  6.  In  
these  reactions  mg  is  operating  together  with  ATP  as  a  kinase  substrate.  
Additionally  a  second  mg  is   bound  to  a  regulatory  site  of  insulin  receptor  
tyrosine  kinase 
10
. 
 
MAGNESIUM  IN  OBESITY: 
          Insulin  resistance  may  be  caused  by  a  reduced  number  of  insulin  
receptors,  by  mutation  of  insulin  receptors  leading  to  reduced  affinity  of  
insulin  binding  or  by  reduced  activity  of  IRTK.  The  most  important  risk  
factor  in  insulin  resistance  is  obesity.  It  has  been  suggested  that  obesity  
induced  insulin  resistance  involves  an  alteration  in  mg  metabolism  plus  
other  mechanisms. 
 
       Obese Zucker  fat  rats  were  used  as  a model  for  the  role  of  obesity  
in  insulin  resistance  and  type  2  diabetes.  Magnesium  supplementation  of  
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obese  rats  resulting  in  a  drop  in  the  blood  glucose  concentration.   These  
studies  showed  the  inverse  association  between  mg  intake  and  metabolic  
syndrome.  The  probable  effect  of  mg  supplementation  may  be  caused  by  
high  mg  concentration  in  intestine,  followed  by  increased    fluid  volume.  
Thus  carbohydrates  and  enzymes  are  more  diluted.  Due  to  Hydrolysis  of  
carbohydrates  within  the  intestinal  lumen,  increase  in plasma  glucose  in  the  
mg supplementated obese zucker  fat  rats may  be  slower  than  in the controls 
10
. 
 
MAGNESIUM  IN  INSULIN  SECRETION  AND  INSULIN  
RESISTANCE  IN  HUMAN: 
 Magnesium  supplementation  in  insulin  requiring  type  2  diabetic  
patients  increased  serum  mg  concentration  from  0.78  to  o.82  mM  and  did  
not  improve  glycemic  control in a study.  In  another  study  mg  
supplementation  of  type  2  diabetic  subjects  increased  serum  magnesium  
concentration  from  0.65  to  0.74  mM  and  induced  a  slight  improvement  in  
glycemia  and  HbA1c.  It  may  be  argued  that  the  serum  mg  concentration  
must  be  significantly  reduced  to  obtain  improved  insulin  sensitivity  and  
metabolic  control  by  mg  supplementation 
10
. 
 
STUDY RELATED TO DIABETES / MICRO NUTRIENTS 
 In  a  Study  done  by  Farideh  Akhlaghi, in  Iran,  measured  
micronutrients (Ni, Al, Cr, Mg, Zn, Cu, Se) level  in  serum  of  gestational  
39 
diabetes  found  that  no  significant  difference between  study  and  control  
group
 11
. 
 
 In  Nigeria  Emmanuel  I.Ugwuja  done  a  study  on  plasma  zinc,  copper  
level  in  pregnant  women  with  diabetes  mellitus.  He  noted  low  serum  zinc  
level  in  diabetic pregnant  women,  may  be  due  to   hyper excretion  of  zinc  in  
urine-  hyperzincuria.  In hyperglycemia  by  interference  with  active  transport  
of  zinc  into  the  renal  tubular  cells 
12
. 
 
 Study  done  by  sae jeong yang  et al  in  korea  showed  that  the  type 2 
DM  group  with previous  gesatational  diabetes  had  the  lowest  serum  
magnesium  level  in  the  post partum  period 
13
. 
 
 Study  by  fadia  mahmoud  showed  that  zinc  level  was  lower  in  
pregnant  women  than non  pregnant  women. but  he  found  that  no  change  in  
zinc  level  in  gdm  mother  as compared  to  normal  pregnant  mother  and  
significant  increase  in  magnesium  level 
14
. 
 
 Correlation  of  serum  zinc,  magnesium  with  type 2 DM  patients  was  
evaluated  by Sunita  pujar,  in  bagalkot.  the  level  of  serum  zinc  and  
magnesium  was  statistically significantly  decreased  in  diabetes  mellitus  
patients  compared  to  healthy  controls 
15
. 
 
40 
 Mohammad  Keshvari  et  al  showed  that  serum  magnesium,  zinc  
concentration  has significant  difference  between  gestational  diabetic  and  non  
diabetic  pregnant women.  serum  zinc  and  magnesium  levels  of  diabetics  
were  less  than  non  diabetic  pregnant women
 16
. 
 
 Effect  of  zinc  supplementation  on  insulin  resistance  was  studied  by  
Neda Roshanravan et  al.  according  to  the  study  there  were  no  significant  
statistical  changes  in  FBS,  serum  insulin  levels  and  HOMA-IR 
17
. 
 
 Rebecca L.Wilson  assessed  the  circulating  zinc  level  and  dietary  zinc  
intake  during pregnancy  and  the  associations  with  pregnancy  complications.  
in  this  study  found that,  circulating  zinc  levels  were  not   different  for  the  
pregnancy  outcomes
18
. 
 
 Meta  analysis  of  prospective  cohort  studies  on  magnesium  intake  and  
risk  of  diabetes was  done  by  Jia -Yi Dong  provides  that  magnesium  intake  
is  significantly  inversely associated  with  type 2  diabetes 
4
. 
 
 J De Haene  found  that  fasting  and  postprandial  zinc  concentrations  
were  higher  in  gdm group  compared  to  IGT  group.  post  prandial  zinc  
concentrations  tended  to  decline  in the  third  trimester  in  all  groups  (NGT, 
IGT, GDM)  but  only  the  fall  in  the  IGT  group was  significant 
19
. 
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  S.Behboudi-Gandevani  in  his  study  he  found  that  there  was  no  
statistical  significant difference  in  zinc  level  and  nutritional  intake  in  early  
pregnancy  with  gestational diabetes 
20
. 
 
 Z Asemil  did  a  study  on  magnesium  supplementation  and  metabolic  
staus  in  gestational diabetics.  he  found  that  magnesium  supplementation  
among  women  with  GDM  had beneficial  effect   on  metabolic  status  and  
pregnancy  outcome 
21
. 
 
 H .Z. Hamdan  found  no  significant  correlation  between  zinc  and  
selenium  and gestaional  diabetes  in  his  study
 22
. 
 Zinc  supplementation  among  GDM  women  had  beneficial  effect  on  
metabolic  profiles- observed  by  Maryam Karamali  in  their  study 
23
. 
 
 A   study  was  done  by  M.Behrashi.  this  study  showed  that  zn  
supplementation  in gestational  diabetes  could  reduce  insulin  needs  and  
improve  glycemic  control  and  it may  also  reduce  macrosomia  incident  rates 
24
 .
 
 
 A  study  was  done  by  TG Kazi,  results  of  this  study  showed  that  
mean  values  of  zn,  mn,  cr  were  significantly  reduced  in  blood  and  scalp  
42 
hair  samples  of  diabetic  patients  as  compared  to  control  subjects  of  both  
genders.  The  urinary  level  of  these  elements  were  found  to  be  higher  in  
the  diabetes  patients  than  in  the  age matched  healthy  controls 
25
. 
 
 Giuseppe paolisso,  Mario barbagallo studied  the  role  of  intra  cellular  
magnesium  in  insulin  resistance.  They  noticed  plasma  magnesium  levels  
were  inversely  correlated  with  metabolic  control  and these  data  suggest  that  
insulin  is  an  important  modulator  of  intracellular  magnesium  control 
26
. 
 
 A  study  done  in  chinese  northeast  population  showed  that  serum  
magnesium  levels  with  IGT,  IFG,  T2D,  T1D  are  significantly  lower  than  
that  of  healthy  control.  The  increased  secretion  of  urinary  magnesium  was  
only  found  in  T2D  and  T1D  patients  as  compared  to  control 
27
. 
 
 Patrick M. Catalano,  John P. Kirwan  found  that  serum  magnesium  
levels  were  lower  in  women  with  type  1  diabetes  compared  with  control  
women.  A  reduction  in  serum  magnesium may  reflect  depressed  tissue  
magnesium  levels.  Lower  lewel  of  straited muscle  magnesium  were  
measured  in  patients  with  diabetes  requiring  insulin 
28
. 
 
 Gestational  diabetes  women  had  significantly  lower  intracellular  free  
magnesium  values  compared  with  nonpregnant  and  normal  pregnant  
individuals  in M Bardicef  study.  These  results  support  the  presence  of  
43 
magnesium  depletion  in  pregnancy  itself  and  to  a  greater  extenet  in  
gestational  diabetes 
29
. 
 
 In  the  third  trimester  the  level  of  ionized  magnesium  was  statistically  
significantly  elevated  in  patients  with  gestational diabetes  compared  to  
controls,  it  was  noted  by  P Ertbeg  in  their  study 
30
. 
 
 In  study  of  MR Nabouli  the  serum  magnesium  concentration  in  
gestational  diabetes  mellitus  women  was  lower  that  of  normal  pregnant  
women but  the  difference  was  not  significant 
31
. 
 
 Serum  level  and  Rbc  magnesium  in  gestational  diabetic  women  was  
less  than  non-diabetic  pregnant  women in  Z A Bouzari  study.  Results  of  the  
study  demonstrated  that  magnesium could  be  an  effective  and  an  underlying  
factor  in  identification  of  disrupted  glucose  metabolism  in  pregnant  women 
32
. 
 F A Mishu evaluated the  serum  magnesium  level  in  bangladeshi  
women.  The  magnesium  level  was  significantly  low  in  second  and  third  
trimesters  in  gdm  cases  compared  to  control  group 
33
. 
 
44 
 E Mostafavi,  A A Nargesi ,  showed  that  abdominally  obese  patients  
with  lower  plasma  magnesium  are  more  likely  to  show  abnormal  OGTT  
results 
34
. 
 
 A  study  was  done  by  M P Genova  and  their  team  on  zinc  level.  The  
survey  did  not  identify  statistically  significant  difference  between  healthy  
pregnant  women  and  those  with  GDM  in  the  level  of  plasma  and  
hemolysate  zinc.  Both  pregnant  groups  had  higher  level  of  intracellular  
erythrocyte  zinc  in  comparison  to  non-pregnant  individuals 
35
 . 
 A  Study  was  done  by  WB Kinlaw  and  team  on  twenty  patients  with  
type  2  diabetes  mellitus  and  found  that  significant  depressed  serum  
concentration  and  hyperzincuria 
36
. 
 
 Antibody  against  zinc  transporter  have  been  detected  in  type 1  
diabetes  mellitus  patients  in  the  study  done  by  J Jansen  and  their  team 
37
. 
 A  study  done  by  J Rungby  demonstrated   that  beta  cell  specific  
knockout  of  Znt8  causes  glucose  intolerance  and  it  affects  the  insulin  
secretion 
38
. 
 Scott  and  Fischer  first  recognized  the  relationship  between  zinc  and  
insulin.  They  found  that  normal   human  pancrease  contained  significant  
quantities  of  zinc   and  the  diabetes  pancrease  contains  very  little 
39
. 
 
45 
 U G Tasdemir  and  his  colleaques  done  a  study  in  pregnant  women  
with   gestational  diabetes.  They  found  that  ionized  and  total  magnesium  
levels  were  lowered  in  GDM  group  as  compared  with  women  with  normal  
OGTT 
40
. 
 
 Farzana Akonjeemishu, MA Muttalib  showed  that  serum  magnesium  
level  was  significantly  lower ( p < 0.001)  in  second  and  third  trimesters  in  
GDM  cases 
7
. 
 
 Diabetic  males  and  females  both  had  significantly (p<0.01)  increased  
zinc  excretory  rates  compared  with  normal  males  and  females.  Urinary  zinc  
excretory  rate  correlated  positively  with  the  degree  of  glycosuria  in  the  
study  done  by  PMC Nair  and  their  team 
41
. 
 
 M Murakami  et  al  examined  the  relationship  between  insulin  secretion  
and  intracellular  free  mg
2+
 in  a  rat  insulinomacell  using  a  fluorescent  dye 
42
. 
 
 C H Sales,  L F C Pedrosa  have  proven  that hypomagnesemia  has  been  
associated  with  diabetes  mellitus  in  their  study 
43
. 
 
 Magnesium  can  be used  for  prognostic  assessment  in  diabetic  
individuals.  It  was  strongly  supported  by   the  study  done  by  V K Srivastava  
46 
and  their  team.  In  their  study  hyperglycemia  was  inversely  related  to  
hypomagnesemia  and  its  restoration  towards  normal  by  insulin  restored  the  
magnesium   concentration  too  and  also  the  magnesium  correlated  with  
major  diabetic  complication 
44
. 
 
 F Mimouni  and  their  team  showed  that  decreased  magnesium   status  
may  contribute  to  the  high  spontaneous  abortion  and  malformation  rate  in  
insulin  dependent  diabetic  pregnant  women 
45
. 
 
 R K Campbell  and  their  team  showed  that  although  lower  intracellular  
magnesium  levels  is  often  reflected  by  hypomagnesemia ( lower  serum  
concentration),  deficiency  often  exists  even  with  normal  serum  levels  of  
magnesium 
46
. 
 
 A  Study  was  done  by  E R Arqilla  and  their  team.  The  study  includes  
invivo  experiments  involved  pretreating  mice  with  zinc  or  sodium  followed  
by   i.p  iodoinsulin  injection  and  found  that  liver  plasma  membrane  isolated  
from  mice  pretreated  with  zinc,  bound  more  iodoinsulin  than  mice  
pretreated  with  sodium.  Ii  demonstrated  that  added  zinc  increased  the  
binding  and  inhibited  the  degradation  of  insulin 
47
. 
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 An  experimental  study  on  the  effect  of  zinc  nutrition  on  insulin  
metabolism  was  done  by  H P Roth  and  M Kirchgessner.  In  this  study  zinc  
deficient  rats  had  unaltered  proinsulin  contents  but  they  showed  a  
diminished  glucose  tolerance,  lowered  serum  insulin  and  an  elevated  insulin  
like  activity 
48
. 
  
 Zinc  supplementation  for  type 2 diabetics  has  beneficial  effect  in  
elevating  their  serum  zinc  level  and   in  improving  their  glycemic  control.  
Patients  supplemented  with  oral  zinc  sulfate  30  mg  of  elemental  zinc/day  
for  3  months.  This  study  was  done  by  R A Al-maroof  and  S S Al-sharbatti  
49
. 
  
 A  study  was  done  by  J J Cunningham  and  R Glenn Brown.  They  
found  that  zincuria  increased  by  a  similar  amount  in  both  groups ( IDDM  
AND  Non  Diabetic)  during  zinc  supplementation  with  50 mg  of  oral  zinc  
for  28  days.  These  data  suggested  a  potential  for  toxicity  from  large  dose  
zinc  supplementation 
50
. 
 
 A  study  was  done  by  J Quarterman,  W R Humphries.  They  found  
reduced  insulin  secretion  and  reduced  glucose  tolerance  in  zinc  deficient  
rats 
51
. 
 
48 
 Insulin  like  effect  of  ionic  zinc   were  studied  in  isolated  rat  adipose  
tissue.  J M May  and  C S Contoreggi  found   that  the  insulin  like  effects  of  
zinc  in  adipocytes  are  not  only  caused  by  direct  effect  on  intracellular  
metabolism,  also  by  indirect  effect  related  to  H2O2  generation 
52
. 
 
 When  deficiency  of  magnesium  is  detected  its  bio organic  salts  with  
high  bioavailability  are  indicated  as  prevention  of  gestational  diabetes  
mellitus 
53
. 
 
 A J Lostroh,  and  Krahl M E  showed  in  their  study  that  insulin  
stimulation  of  magnesium  accumulation  is  dependent  on  an  actively  
functioning  Na
+
 / K
+
 ATPase  system 
54
. 
 Insulin  and  glucose  are  important  regulator  of  magnesium  
metabolism.  Intracellular  magnesium  plays  a  key  role  in  regulating  insulin  
action,  insulin  mediated  glucose  uptake 
55
. 
 
 M Rodriquez,  F G Romero  were  done  a  double  blind  placebo  control  
trial   in  diabetic  subjects  with  decreased  serum  magnesium  levels.  Oral  
supplementation  with  magnesiumchloride  solution  restores  the  serum  
magnesium  levels  and  improving  insulin  sensitivity  in  diabetic  subjects  
received  50 ml  mgcl2  orally  for  16  weeks  than  diabetic  subjects  received  
placebo 
56
.  
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  Maternal  plasma  concentration  of  zinc,  magnesium  was  estimated  by  
Borella P and  their  team.   They  found   significant  decrease  in  magnesium  in  
pregnant  women  with  diabetes  but  increase  in  plasma  zinc  was  observed.  
This is  probably  as  a  result  of  reduced  zinc  uptake  by  the  fetus 
57
. 
 
 Serum  zinc  concentration  in  the  first  trimester  of  human  pregnancy  
were  evaluated  in  106  pregnant  women.  No  difference  was  found  in  serum  
zinc  level  between  diabetics  and  non  diabetic  subjects  in  the study  done  by  
Breskin  et  al 
58
. 
 
 Prenatal  iron  supplementation  may  adversely  affect  maternal  zinc  
status.  This  was  observed  by  Hambidge K M and  team.  In  their  study  
prenatal  iron  supplementation  was  negatively  correlated  with  alkaline  
phosphatase  activity  and  plasma  zinc  in  second  and  third  trimester 
59
. 
 
 Lie J and  their  team  done  a  study  in  chinese  pregnant  women.  They  
observed  the  concentration  of  calcium,  copper,  magnesium  were  altered  
during  all  the  trimesters  of  pregnancy  and  zinc  levels  are  altered  during  
mid  and  late  pregnancy  and  postpartum 
60
. 
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 Zinc  ions  enhances  proinsulin  solubility  and  also  play  an  important  
role  in  microcrystalline  character  of  the  precipitated  insulin  granule 
61
. 
 
 P Delva  and  team  studied  the  interact  of  the  effect  of  insulin  and  
glucose  on  intracellular  ionized  magnesium  in  human  lymphocyte.  
Magnesium  was  measured  using  a   fluorimetric  method.  Insulin  capable  of  
increasing  intracellular  magnesium  by  modulating  the  activity  of  Na / Mg  
transport  system 
62
. 
 
 The  american  diabetes  association  has  published  a  statement  
suggesting  that  patients  who  have  documented  hypomagnesemia  and  
diabetes  mellitus  receive  magnesium  supplementation  based  on  the study  
done  by  J R White, R K Campell 
63
. 
 R Lopez Riraura  et  al  done  a  study  in  85060  women and  42872  men  
who  had  no  history  of  diabetes.  Magnesium  intake  was  evaluated  using  a  
validated  food  frequency  questionnaire  every  2-4  years  and  found  the  
significant  inverse  association  between  magnesium intake  and  diabetes  risk 
64
. 
 
 Hypomagnesemia  has  been  linked  both  to  the  acute   metabolic  and  
late  chronic  complication  of  diabetes 
65
. 
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 In  a  study  done  by  A H Zargar  et  al  found  that  zinc  and  magnesium  
levels  are  not  altered  in  NonInsulin Dependent Diabetes Mellitus (NIDDM) 
66
. 
 
 A  review  was  done  by  L M Dalton  and  their  team on  magnesium  in  
pregnancy.  This  study  provides  recommend  for  further  study  using  
measurement  of  red  cell  magnesium  level  to  know  the  magnesium  status  
rather  than  serum  magnesium  level.  Though  serum  magnesium  is  the  most  
widely  used  method  but  it  has  significant  limitations 
67
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MATERIALS AND METHODS 
 
  
METHODOLOGY 
 
Study  design:  Cross  sectional  study 
Study  place:  Department  of  Obstetrics & Gynecology,  Coimbatore  Medical  
College & Hospital,  Coimbatore. 
Study  period:  July  2016  to  June  2017. 
Study  subjects:  A  total  of  sixty  pregnant  women  with  primigravida  in  the  
age  group  of  20 - 35  years  were  selected  for  my  study  from  the  department  
of  Obstetrics & Gynecology ( O & G)  after  getting  their  consent.  Thirty  
pregnant  women  who  diagnosed  having  Gestational  Diabetes  Mellitus 
(GDM)  by  75 gm  OGTT ( Oral  Glucose  Tolerance  Test ),  with  the  blood  
sugar  level  of  ≥ 140 mg / dl  after  2  hours  of  oral  glucose  were  considered  
as  GDM  group ( cases ),  and  control  group  comprised  of  30  primi  normal  
pregnant  women  without  gestational  diabetes  mellitus. 
Inclusion  Criteria: 
 30  primi  pregnant  women  diagnosed  having  GDM  who   were  age  as  
well  as  BMI  matched. 
 30  normal primi   pregnant  women  who  were  also  age  and  BMI  
matched. 
 Pregnant  women  having  antenatal  records  with  height / weight  at  first  
booking  visit  were  included.  
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 Pregnant  women  were  evaluated  for  the  concentration  of    Zinc ( Zn )  
and    Magnesium ( Mg )  in  the  serum  during  24  to  28  weeks  of  
gestational  age. 
EXCLUSION  CRITERIA:    
 Multiple  pregnancy 
 Abnormal pregnancy 
 Obesity (BMI > 30Kg/m2) 
 PCOD 
 Pre gestational  diabetes 
 Elderly  primi ( Age > 35 years) 
 Primi  with  medical  disorders  like  Hypertension,  Diabetes,  Heart  
disease,  Liver  and  Renal  disorder,  Epilepsy,  Skin  diseases  and  Drug  
intake. 
 
MATERIALS: 
Proforma  -  To  obtain  a  detailed  history  and  clinical  examination  findings. 
Auto  analyser  -  To  analysis  blood  sugar  level. 
Photometry  -  To  measure  serum  magnesium ,  zinc  concentration. 
METHODOLOGY: 
 After  obtaining  clearance  from  institutional  ethical  committee,  subjects  
were  selected  from  the  outpatient  clinic  in   the  department  of  obstetrics & 
54 
gynecology  to  my  study.  Subjects  were  explained  about  the  procedure  in  
detail  and  informed  consent  was  obtained.  A  total  of  sixty  pregnant  women  
of  primi  gravida  were  selected  in  the  age  group  of   20  to  35  years.  All  
the  subjects  were  underwent  GDM  screening  with  75  gram  oral  glucose 
tolerance  test  in  the  second  trimester.  After  their  results,  subject  with  blood  
glucose  level  of  ≥ 140 mg / dl  were  selected  as  cases  ( GDM  group )  and   
subject  with  blood  glucose  level  of  < 140  mg / dl  were  considered  as  
control  group. 
 
HISTORY  TAKING  &  CLINICAL  EXAMINATION: 
 Detailed  history  was  elicited  from  the  cases  and  controls  to  rule  out  
signs  and  symptoms  of  pregestational  diabetes,  cardio  vascular,  renal,  liver  
diseases  and    intake  of  any  drugs.  Last  menstrual  period (LMP )  was  noted,  
and  weeks  of  pregnancy  was  calculated  using  Naegele's  rule  ( Add  7  days  
to  the  first  day  of  LMP  and  count  back  3  months ).  General  examination  
was  done. 
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HISTORY TAKING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BMI  ( Body  Mass  Index )  MEASUREMENT: 
 The  height  as  well  as  weight  recorded  during  the  first  visit  of  
antenatal  checkup  were  obtained  from  the  antenatal  records  and  BMI  was  
calculated  using  Quetelet's  index. 
 
QUETELET'S  INDEX: 
Body Mass Index (BMI ) =  Weight  in  kg  /  Height  in  m
2
 
 The  subjects  were  selected  with  a  BMI  between  18.5  to  24.99  kg/m
2
  
which  includes  women  with  normal  BMI  according  to  WHO  (  World  
Health  Organization )  criteria. 
 
BLOOD  INVESTIGATION:  (  Done  in  all  subjects ) 
1.  TWO  HOUR  75 gm  OGTT -   (WHO   CRITERIA) 
 The  test  was  done  at  24  to  28  weeks  of  pregnancy.  it  was  done  
irrespective  of  the  last  meal.  It  is  a  screening  test  for  gestational  diabetes  
mellitus. 
 All  the  pregnant  women  were  given  a  75 gm  glucose  load  orally  in  
the  antenatal  clinic,  then  a  blood  sample  was  collected  from  a  peripheral  
vein  after  2  hours  and  the  estimation  of  plasma  glucose  was  done  using  
glucose  oxidase  peroxidase  technique. 
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 ORAL GLUCOSE TOLERANCE TEST 
  
OGTT  RESULTS: 
Blood  glucose  level  of  ≥ 140 mg / dl  -  Abnormal.  Subjects  with  this  value  
taken  as  cases. 
Blood  glucose  level  of  < 140 mg / dl  -  Normal.  Subjects  with  this  value  
taken  as  controls. 
 
SERUM  ZINC  &  MAGNESIUM  MEASUREMENT: 
It  was  done  in  both  groups  of  subjects  ( case  &  control ). 
 In  all  subjects  the  antecubital  vein  in  front  of  forearm  was  selected  
for  venous  blood  sample.  The  skin  over  the  vein  was  cleaned  with  spirit &  
cotton  and  allowed  to  dry.  Then  a  disposable  sterile  needle  fitted  with  5  
ml  syringe  was  introduced  and  4 ml  of  blood  was  collected  and  poured  
into  separate  container.  The  serum  was  separated  from  this  sample  by  
centrifuging  the  blood to  3000  rpm  for  five  minutes.  And  the  serum  was  
used  to  estimate  the  serum  zing  and  magnesium  levels  immediately. 
ZINC  ;  NITRO  -  PAPS  METHOD :  (CALORIMETRIC  METHOD) 
The  estimation  of  serum  zinc  was  done  using  NITRO  -  PAPS  method. 
PRINCIPLE: 
Zinc  reacts  with  Nitro  -  PAPS  reagent  in  alkaline  medium  to  form  a  
purple  coloured  complex. 
NORMAL  VALUE:  70  -  115 µg / dl. 
57 
VENOUS BLOOD SAMPLE COLLECTED FOR ZINC AND 
MAGNESIUM MEASUREMENT  
MAGNESIUM  :  MODIFIED    XYLIDYL  BLUE  REACTION  
METHOD: 
 The  estimation  of  serum  magnesium  was  done  using  Modified    
xylidyl  blue  reaction  method.  
PRINCIPLE: 
 Magnesium  determination  is  based  on  the  reaction  of  magnesium  
with  xylidyl  blue  at  alkaline  pH,  which  yields  a  purple  coloured  complex. 
NORMAL  VALUE :  1.30  -  2.70  mg / dl. 
NORMAL  VALUES  OF  ZINC,  MAGNESIUM  AND  OGTT: 
Parameters Normal Values 
OGTT In  Pregnancy: 
< 140 mg / dl (Normal) 
 ≥ 140mg/dl   (GDM) 
Zinc 70 – 115 µg / dl 
Magnesium  1.30 – 2.70 mg / dl 
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STATISTICAL ANALYSIS   
STATISTICAL TOOLS 
 The data obtained from the current study were documented in a Master 
Chart. Data Analysis was done using statistical packaging of social science – 
SPSS Version 24. 
 Employing the above software calculations of the mean, standard 
deviations (SD), percentages and ‘p’ values were done. Student ‘t’ test was 
employed to analyse the significance of difference between the quantitative 
variables (age, BMI, Zinc, Magnesium, OGTT). Chi square test is used for 
qualitative variables (diet, residence, family history). A significant association is 
considered only when the ‘p’ value is less than 0.05. 
 Microsoft power point was employed to prepare graphs. 
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RESULTS 
  
RESULTS 
Table 1:  AGE DISTRIBUTION BETWEEN THE GDM GROUP AND 
  THE CONTROL GROUP. 
Age  Case (GDM) Control P value 
20-25 
 
26(49.1%) 27(50.9%)  
 
0.688 
26-30 
 
4(57.1%) 3(42.9%) 
p- value  > 0.05  -  not  statistically  significant. 
Figure : 1  AGE  DISTRIBUTION 
 
                              20-25 YEARS                     26-30 YEARS 
 
 In  this  study  there  is  no  statistically  significant  difference  in  age  
distribution  between  GDM  group  and  control  group. 
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Table 2:  MEAN  AGE 
  
GROUPS 
 
N 
Mean 
Standard  
Deviation(SD) 
 
 
Range  
'P' 
VALUE 
 
Age 
Case 30  22.60 2.358 20-29  
 0.687 
 Control 
 
30 22.37 2.092 20-27 
 
Not  statistically significant  ( p > 0.05) 
Figure : 2    MEAN  AGE 
 
 
 There  is  no  statistically  significant  difference  in  age  distribution  
between  GDM  group  and  control  group. 
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Table 3 :   DISTRIBUTION OF RESIDENCE BETWEEN GDM GROUP 
  AND CONTROL GROUP 
 
Residence Case (GDM) 
group 
Control group 'P' value 
Rural  
 
8(57.1%) 6(42.9%)  
 
0.542 
Urban  
 
22(47.8%) 24(52.2%) 
p -value  :  0.542  ( > 0.05),  Not  significant. 
 
 
Figure : 3   RESIDENCE  
 
 
 
 There  is  no  significant  difference  in  residence  distribution  between  
GDM group  and  control  group.  
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Table 4 :   BMI DISTRIBUTION BETWEEN GDM GROUP AND  
  CONTROL GROUP 
 
  
GROUPS 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
BMI 
Case 
 
30 23.50 1.7  
0.002* 
 Control 
 
30 22.18 1.4 
 
*- STATISTICALLY SIGNIFICANT (P<0.05) 
 
Figure : 4     MEAN  BMI 
 
 
 
 
 The  above  results  show  significant  difference  in  BMI  distribution   
between  GDM  group  and  control  group. 
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Table 5 :  FAMILY HISTORY OF DIABETES MELLITUS 
 
Family h/o DM Case(GDM) Control 'P' value 
Yes  
 
17(41.5%) 24(58.5%)  
 
0.052 
No  
 
13(68.4%) 6(31.6%) 
 
p > 0.05,  Not  statistically  significant. 
 
 
FIGURE : 5     FAMILY  HISTORY  OF  DIABETES  
 
 
 
 
 Both  groups  show  no significant  difference  in  distribution  of  family  
history  of  diabetes  mellitus. 
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Table 6  :   DIET HABITS BETWEEN GDM GROUP AND CONTROL 
  GROUP 
 
Diet Habit Case(GDM) Control 'P' value 
Non -vegetarian 
 
27(51.9%) 25(48.1%)  
 
0.448 
Vegetarian  
 
3(37.5%) 5(62.5%) 
 
'p' -  value :  0.448  (Not  significant). 
 
 
 
FIGURE : 6      DIET  HABITS 
 
 
 
Both  groups  show  no  significant  difference  in  the  diet  habit. 
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Table  7 :   OGTT VALUES BETWEEN GDM AND CONTROL GROUP 
 
  
GROUPS 
 
Number 
Mean 
Standard  
Deviation(SD) 'P ' value 
 
OGTT 
Case 
(GDM) 
 
30 150.80 8.08  
.000* 
 
Control 
 
30 121.20 6.17 
*- STATISTICALLY SIGNIFICANT (P<0.05) 
 
 
FIGURE : 7   OGTT  VALUES  BETWEEN  GDM  GROUP  AND  
CONTROL GROUP 
 
 
 
 There  is  statistically  significant  difference  in  OGTT  values  between  
GDM  group  and  control  group. 
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Table 8 :   ZINC LEVELS BETWEEN GDM GROUP AND CONTROL 
  GROUP  
  
GROUP 
 
N 
Mean 
Standard  
Deviation(SD) 'P' VALUE 
 
Zinc  
Case 
(GDM) 
 
30 59.61 8.0  
.000* 
 
Control 
 
30 69.07 10.8 
 
*- STATISTICALLY SIGNIFICANT (P<0.05). 
 
FIGURE : 9  ZINC  LEVEL  IN  GDM  GROUP  AND  CONTROL  
GROUP 
 
 
 
 
  Mean  zinc  in  GDM  group  was  59.61  µg / dl,  and  the  level  of  mean  
zinc  in  normal  primi  gravida ( control  group)  was  69.07  µg/ dl.  The  p- value  
is  0.000 (<0.05)  statistically  significant.  Zinc  level  in  the  GDM  group  was  
significantly  lower  than  control  group.  
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Table 9 :   MAGNESIUM LEVEL BETWEEN GDM GROUP AND  
  CONTROL GROUP 
  
GROUP 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Magnesium  
Case 
(GDM) 
 
30 1.69 .33  
0.598 
 
Control 
 
30 1.74 .33 
 
NOT  STATISTICALLY  SIGNIFICANT ( p - 0.598) 
 
 
FIGURE : 10  MAGNESIUM  LEVEL  IN  GDM  GROUP  AND   
    CONTROL  GROUP 
 
 
 
 
 Mean  magnesium  in  GDM  group  was  1.69 mg/ dl,  and  mean  
magnesium  in  control  group  was  1.74  mg / dl.  The  'p'  value  is  0.598.  There  
is  no  significant  difference  in  magnesium  level  in  both  the  groups. 
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ASSOCIATION BETWEEN ZINC AND OTHER VARIABLES IN GDM 
GROUP 
Table 10 :  AGE & ZINC LEVELS 
 
  
Age  
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Zinc   
20-25 26 58.51 
 
7.1  
0.219 
 26-30 4 66.80 
 
10.6 
 
NOT  STATISTICALLY  SIGNIFICANT ( P : 0.219) 
 
FIGURE : 10   AGE  &  ZINC  LEVELS  
 
 
                                                 20-25                                  26-30  (Age  in  years) 
 
There  is  no  significant  relation  between  age  and  zinc  level  in  GDM  group. 
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Table 11 :   DISTRIBUTION OF RESIDENCE & ZINC LEVELS IN GDM 
  GROUP 
 
  
Residence 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Zinc   
Urban 22 59.81 8.6  
0.824 
 Rural 8 59.06 6.2 
 
FIGURE : 11   RESIDENCE  &   ZINC  LEVELS 
 
 
 
 
 There  is  no  relation  between  rural  &  urban  residential  distribution  
and  zinc  level  in  GDM  group. 
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Table 12 :  BMI & ZINC LEVELS 
  
BMI 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Zinc   
18.50-
24.99 
 
26 60.78 7.9  
0.039* 
 
25.00-
29.99 
 
4 52.02 1.0 
 
'p'  value   0.039 (< 0.05) ;  significant. 
 
FIGURE : 12  BMI  &  ZINC  LEVELS 
 
 
                                           18.50-24.99                                       25.00-29.99 
 
 
 In  the  GDM  group,  mean  zinc  in  the  subjects  with  normal  BMI was  
60.78µg / dl  and  mean  zinc  level  in  overweight  GDM  group  was  52.02 µg / 
dl.  p  value  was  statistically significant.  The  above  results  show  deficiency  
of  zinc  level  was  increase  with  overweight . 
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Table 13 :  FAMILY HISTORY OF DM & ZINC LEVELS 
  
Family  
history 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Zinc   
YES 
 
13 56.95 6.86  
0.113 
 NO 
 
17 61.65 8.41 
 
'p'  value  0.113  (>0.05)  Not  Significant. 
 
 
FIGURE : 13  FAMILY  HISTORY  OF  DIABETES  AND  ZINC  LEVELS 
 
 
                                               YES                                                 NO 
 
 In  the  GDM  group  there  is  no  statistically  significant  difference  in  
zinc  level  between  subjects  with  positive  family  history  and  subjects  with  
no  family  history  of  diabetes  mellitus 
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Table 14 :  DIET HABIT & ZINC LEVELS IN GDM GROUP 
 
  
Diet  
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Zinc   
NON-
VEGETARIAN  
27 59.23 7.4  
0.446 
 
VEGETARIAN 3 63.03 13.5 
 
'p'  value-  not  significant  (0.446). 
 
 
FIGURE : 14  DIET  HABIT  &  ZINC  LEVELS 
 
 
 
 
 The  above  results  show  no  significant  difference  of  zinc  level  
between  vegetarian  and  non-vegetarian  in  GDM  group. 
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ASSOCIATION BETWEEN MAGNESIUM AND OTHER VARIABLES IN 
GDM GROUP. 
Table 15 :  AGE & MAGNESIUM LEVELS 
  
Age  
 
No 
Mean 
Standard  
Deviation(SD) 'P 'value 
 
Magnesium    
20-25 26 1.75 
 
.29  
0.103 
 26-30 4 1.34 .36 
 
'p'   0.103 ;  Not  Significant. 
 
FIGURE : 15  AGE  &  MAGNESIUM  LEVELS 
 
 
                                               20-25                                            26-30 
 
There  is  no  significant  relation  between  age  and  magnesium  level  in  GDM  
group. 
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Table 16 :   BMI & MAGNESIUM LEVEL IN GDM GROUP 
  
BMI 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Magnesium    
18.50-
24.99 
 
26 1.69 .34  
0.714 
 
25.00-
29.99 
 
4 1.75 .29 
 
p   value :  0.714 (>0.05),  Not  Significant. 
 
FIGURE : 16  BMI  &  MAGNESIUM  LEVELS 
 
 
                                           18.50-24.99                                       25.00-29.99 
 
 In  GDM  group  mean  magnesium  of  subjects  with  normal  BMI  was   
1.69 mg / dl, and  mean  magnesium  level  in  subjects  with  overweight  was  
1.75 mg / dl.  There  is  no  statistically  significant  difference  between  BMI  
distribution  and  magnesium  level .  
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Table 17 :  FAMILY HISTORY OF DM & MAGNESIUM IN GDM GROUP 
  
Family 
history 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Magnesium    
YES 
 
13 1.77 .26  
0.276 
 NO 
 
17 1.64 .37 
 
p  value  0.276  (> 0.05)  Not  significant. 
 
 
FIGURE : 17  FAMILY  HISTORY  OF  DIABETES  AND  MAGNESIUM  
LEVELS 
 
 
                                               YES                                                 NO 
 
 There  is  no  significant  relation between  family  history  of  diabetes  
mellitus  and  magnesium  level  in  GDM  group. 
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 Table 18 :  RESIDENCE & MAGNESIUM LEVEL IN GDM GROUP 
 
  
Residence 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Magnesium    
Urban 22 1.77 .29  
0.994 
 Rural 8 1.50 .37 
 
p  value ;  0.994  -  Not  Significant. 
 
 
FIGURE : 18  RESIDENCE  &  MAGNESIUM  LEVELS 
 
 
 
 
 
 No  significant  difference  in  magnesium  level  between  rural  and  urban  
residential  distribution  in  GDM  group. 
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 Table 19 :  DIET HABIT & MAGNESIUM LEVEL 
 
  
Diet 
 
No 
Mean 
Standard  
Deviation(SD) 'P' value 
 
Magnesium    
NON-
VEGETARIAN  
27 1.67 .33  
0.151 
 
VEGETARIAN 3 1.96 .15 
 
'p'  value ; 0.151 (>0.05) :  Not  Significant. 
 
FIGURE  :  19  DIET  HABIT  &  MAGNESIUM  LEVELS 
 
 
 
 There  is  no  significant  difference  in  magnesium  level  between  
vegetarian  and  non-vegetarian  in  GDM  group. 
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Table 20 :  CORRELATION BETWEEN  OGTT AND ZINC 
 
 
 
 
No 
Mean 
Standard  
Deviation(SD) 
 
Correlation 
'P' value 
OGTT 30 150.80 8.08  
- 0.226 
 
0.231 
 Zinc 30 59.617 8.01 
 
 
 
 
 Correlation  coefficient  between  blood  sugar  levels  by  OGTT  and  zinc  
is   found - 0.226 ( negative  correlation).  This  show  that  as  the  zinc  level  
decreases   the  blood  sugar  level  increase  in  women  with  GDM. 
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Table 21 :  CORRELATION BETWEEN OGTT AND MAGNESIUM 
 
 
 
N 
Mean 
Standard  
Deviation(SD) 
 
Correlation 
'P' value 
OGTT 30 150.80 8.08  
- 0.058 
 
0.113 
 Magnesium 30 1.69 .33 
 
 
 
 Correlation  coefficient  between  blood  sugar  levels  by  OGTT  and  
magnesium  is  found  - 0.058 (negative correlation).  This  shows  that  as  
magnesium  level  decreases  the  blood  sugar  level  increases  in  women  with  
GDM. 
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DISCUSSION 
 
  
DISCUSSION 
 Pregnancy  is  a  state  of  insulin  resistance.  Many  maternal  hormones  
and  factors  play  a  role  in  causation  of  insulin  resistance  during  pregnancy.  
Insulin  resistance  during  pregnancy  due  to  alteration  in  the  hormonal  level  
such  as  growth  hormone,  cortisol,  human  placental  lactogen  and  insulinase  
secretion.  In  healthy  pregnant women  insulin  resistance  is  compensated  by  
pancrease,  but  in gestational  diabetes  mellitus  women  there  is  a  impaired  
beta  cell  function. 
 
Gestational  diabetes  mellitus  is  defined  as  glucose  intolerance  that  
begins  or  is  first  recognized  during  pregnancy.  Women  without  diabetes  
develops  high  blood  sugar  levels  during  pregnancy.  Babies  born  to  mothers  
with  poorly  treated  gestational  diabetes  are  at  increased  risk  of  being  too  
large,  having  low  blood  sugar  after  birth  and  jaundice.  Longterm  children  
are  at  higher  risk  of  being  overweight  and  developing  type  2  diabetes  
mellitus. 
 
 GDM   is  caused  by  not  enough  insulin  in  the  setting  of  insulin  
resistance.  In  a  normal  pregnancy  insulin  resistance  develop  in  the  second  
trimester  and  continues  until  birth.  It  is  beleived  to  be  related  to  the  
production  of  hormones,  cytokines,  adipokines  by  the  placenta.  Gestational  
diabetes  develops  because  of  preexisting  increase  insulin  resistance  and  
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diminished  insulin  secretion.  During  pregnancy  the  imbalance  between  
insulin  resistance  and  secretion  may  lead  to  hyperglycemia. 
 
 Women  with  GDM  are  often  asymptomatic,  so  screening  is  important  
for  detection.  Screening  protocol  for  GDM  is  controversial.  Screening  may  
consist  of  either  a  one  step  0approach  or  a  two  step  approach.  The   one  
step  approach  was  initially  recommended  by  the  ADA  in  2011.  It  involves  
a  75g  OGTT  at  24- 28  weeks  gestation.  Women  who  are  at  risk  of  
preexisting  diabetes  should  be  screened  at  their  first  prenatal  visit. Routine  
screening  of  women  with  a  glucose  challenge  test  appears  to  find  more  
women  with  gestational  diabetes  than  only  screening  women  with  risk  
factors. A  women  is  considered  low  risk  if  age  less than  25  years,  BMI  
less  than  25  before  pregnancy,  not  of  american  indian,  asian  women,  
hispanic,  african  american,  no  first  degree  relative  with  diabetes  mellitus,  
no  history  of  poor  obstetric  outcome.  A  women  is  considered  high  risk  if  
all  of  the  following  factors  are  present  history  of  macrosomia,  age  >  25  
years,  BMI  >  30,  ethnic  group  with  a  higher  rate  of  type  2  diabetes,  
strong  family  history  of  diabetes,  unexplained  stillbirth,  persistent  glycosuria.  
 
  The  specific  aim  of  this  study  was  to  pursue  possible  relationships  
between  serum  concentration  levels  of  zinc  and  magnesium  micronutrients  
and  gestational  diabetes  mellitus.  GDM   is  a  complex  metabolic  syndrome  
and  many  factors  are  contributed  in  this  disorder.  The  causes  of  gdm  are  
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multifactorial  and  may  include  genetic  and  environmental  factors  that  
influence  insulin  sensitivity.   
               
 Zinc  is  mainly  an  intracellular  element.  Zinc  is  found  in  many  foods.  
The  main  sources  of  zinc  are  meat,  fish,  egg,  milk,  beans,  nuts.  Zinc  is  
absorbed  mainly  in  duodenum.  Zinc  is  better  absorbed  from  animal  foods  
than  from  plant  foods  since  phytate  hinder  its  absorption.  Zinc  is  an  
essential  component  of  several  enzymes.  How  does  zinc  relate  to  diabetes?  
Interestingly  zinc  has  long  been  an  ingredient  used  in  older  insulins.  Zinc  
is  also  necessary  for  the  storage  and  secretion  of  insulin  from  the  beta  
cells  of  pancrease.  Insulin  is  stored  inside  secretory  vesicles  or  granules  
where  2  zinc  ions  coordinate  six    insulin  monomers  to  form  hexameric  
structure  on  which  matured  insulin  crystals  are  based.  Only  a  small  portion  
of  insulin  stored  in  vesicles  released  even  under  maximum  stimulation,  this  
suggest  that  insulin  synthesis  are  regulated  by  secretion  rather  than  
synthesis  and  is  not  ordinarly  limited  by  size  of  storage  pool.  Zinc  affects  
insulin  signalling  pathway.  Zinc  potentiates  the  motogenic  signalling  of  
insulin  and  activates  extracellular  signal  regulated  kinases  1  and  2  
5
 .   Zinc  
has  insulin  like  function,  increase  the  glucose  transport  into  rat  epididymal  
adipocytes  through  a  post  insulin  receptor  mechanism 
68
. 
             
  Magnesium  is  the  fourth  most  abundant  cation  in  the  body.  70%  of  
which  is  found  in  bones  in  combination  with  calcium  and  phosphorous.  
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The  main  sources  of  magnesium  are  cereals,  nuts,  beans,  cabbage,  
cauliflower,  meat,  milk,  fruit.  Magnesium  is  absorbed  by  the  intestinal  cells  
through a  specific  carrier  system.  About  50%  of  the  dietary  magnesium  is  
normally  absorbed.  Consumption  of  large  amount  of  calcium,  phosphate  and  
alcohol  diminishes  magnesium  absorption. Homeostasis  is  maintained  by  
intestinal  absorption  as  well  as  by  renal  excretion.   Magnesium  is  the  
activator  of  many  enzymes  requiring  ATP.  Magnesium  plays  a  key  role  in  
carbohydrate  metabolism.  Magnesium  may  influence  the  release  and  activity  
of  hormones  that  control  blood  glucose  level  via  tyrosine  kinase.  Insulin  
dependent  absorption  of  glucose  requires  magnesium.   
                   
 Mohammad  Keshvri   Delavan  et  al.,   found  that  mean  of  magnesium,  
zinc  in  mothers  of  both  group  (  gestational  diabetic  group  &  non  diabetic  
pregnant women  )  had  no  significant  difference.  GDM  group  showed  mean  
zinc  67.44  +_  12.1,  compared  to  normal  group  73.34 +- 10.8,  with  p- value 
of  0.11  and  found  no  significant  difference  between  serum  zinc  level  in  
GDM  and  normal  group.  Mean  magnesium  in  GDM  group  was  1.84 +- 
0.15,  whereas  mean  magnesium in  normal  group  was  1.86 +- 0.10,  with  p -  
value  0.71,  it  is  not  significant 
16
. 
                        
   Farideh  Akhlaghi  et  al.,  found  in  their  study  that  there  was  no  
significant difference  between  GDM  and  normal  control  group  in  serum  zinc  
and  magnesium  level 
11
.  
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  The  observation  of  Emmanuel  I.  Ugwuja  was  that  low  serum  zinc  
level  in  diabetic  pregnant  women  may  be  due  to  hyperexcretion  of  zinc  in  
urine 
12
. 
 
 Fadia  Mahmoud   et  al.,  also  concluded  that  lower  level  of  
magnesium  is  seen  in  normal  pregnancy  compared  to  non-pregnant  women.  
The  p - value  is  < 0.01 . Significant 
14
. 
 
 Sunita  Pujar  et  al.,   found  that  level  of  serum  zinc  and  magnesium  
was  statistically  significantly   decreased  in  diabetes  mellitus  patients  
compared  to  healthy  controls.  Mean  zinc  in  control  group  was  89.61 +- 
27.74,  whereas  mean  zinc  in  diabetes  mellitus  group  was  67.50 +- 13.85.  
Similarly  mean  magnesium  was  lower  in  diabetes  mellitus  group  compared  
to  normal  control  group.  mean  magnesium  in  control  group  was  2.43 +- 
0.42,  mean  magnesium  in  DM  group  was  2.01 +- 0.39,  ( p - value ;  < 0.001 
),  highly  significant 
15
. 
                   
 The  observation  of  P.  Ertbeg  et  al  was  that  the  level  of  ionized  
magnesium  was  statistically  significantly  elevated  in  patients  with  gestational  
diabetes  compared  to  controls.  Mean  magnesium  in  GDM  group  was  0.57 
+- 0.05 mmol / L,  but  in  control  group  mean  magnesium  was  0.51 +- 0.06 
mmol / L,  P - value  is  significant  ( < 0.01 ) 
30
.  
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  In  the  present  study   30  women  with  primi  GDM  were  taken  as  
GDM  group  and  30  women  with  normal  primi  who  were  age  and  BMI  
matched  as  control  group.  The  study  was  done  between  24   to  28  weeks  of  
pregnancy  as  the  diabetogenic  tendency  is  maximum  after  second  trimester  
or  pregnancy  due  to  the  peaking  of  placental  hormones  which  is  done  
similar  to  the  studies  by  Farideh  Akhlaghi  et  al 
11
  . 
                   
 The  current  study  inferred   that  the  mean  concentration  of  zinc  was  
statistically  lower  in  GDM  group  as  compared  to  controls.  The  mean  zinc  
concentration  in  the  GDM  group  was  59.61 µg / dl.  The  mean  zinc  level  in 
control  group  was  69.07 µg / dl.  In  GDM  group,  an  increased  occurence  of  
zinc  deficiency  was  observed  in  this  study.  It  is  unknown  whether  
reduction  in  serum  zinc  concentration  is  a  predisposing  factor  for  GDM  or  
pregnant  women  with  hyperglycemic  status  have  low  serum  zinc  levels.  
Mean  concentration  of  magnesium  was  lower  in  GDM  group  as  compared  
to  controls,  but  it  was  not  statistically  significant.  The  mean  magnesium  
concentration  in   the  GDM  group  was  1.69 mg /dl,  the  mean  magnesium  
level  in  control  group  was  1.74 mg / dl. 
         
 In  current  study,  90%  of  women  with  GDM  showed  zinc  deficiency  
and  women  with  normal  OGTT  showed  63%  zinc  deficiency.  The  
decreased  level  of  zinc  during  pregnancy  may  be  due  to  increased  demand 
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and  low  absorption  of  zinc  from  duodenum  in  the  presence  of  calcium,  
iron.  The  deficiency  of  zinc  in  GDM  may  be  due  to  hyperzincuria. 
 
RELATIONSHIP  BETWEEN  ZINC  AND  OTHER  VARIABLES: 
 In  the  current  study,  zinc  level  was  correlated  with  different  
parameters  like  age,  BMI, diet,  residence  among  the  GDM  group. 
 
Age  and  Zinc  Levels: 
 The  mean  level  of  zinc  between  20  to 25  years  of  age  was  58.51 µg 
/ dl,  and  the  mean  level  of  zinc  between  26  to  30  years  was  66.80 µg / dl.  
The  p - value  obtained  was  0.219  and  found  to  be  not  significant. 
 
BMI  and  Zinc  Level: 
 In  the  present  study,  women  with  normal  BMI  were  included.  As  
obesity  itself  is  found  to  increase  the  chance  of  developing  GDM,  obese  
women  were  excluded  from  the  study.  The  mean  BMI  in  GDM  group  was  
23.50  kg / 
m2
.  The mean  zinc  level  was  60.78 µg / dl  in  women  with  normal  
BMI  and  52.02 µg / dl  in  women  with  overweight,  and  the  p - value  was  
found  to  be   significant (0. 039). 
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Family  history  of  diabetes  and  Zinc  Level: 
 Mean  zinc  in  GDM  group  with positive  family  history  of  diabetes  
was  56.95 µg / dl.  Mean  zinc  in  GDM   group  with  no  family  history  of   
diabetes  mellitus  was  61.65 µg / dl,  mean  zinc  level  was  higher  in  GDM  
group  with  no  family  history  of  diabetes  than  GDM  group  with  positive  
family  history,  but  the  p - value  is  not  statistically  significant ( p :  0.113 ). 
 
Residence  and  Zinc  Level: 
 There were  8  out  of  30  subject  with  GDM  from  rural  areas  and  
remaining  22  subjects  of  GDM  group  were  from  urban  areas.  Mean  zinc  in  
subjects  with  urban  residence  was  59.81  µg / dl  and  mean  zinc  in  subjects  
with  rural  residence  was  59.06  µg / dl.  The  p - value  is  0.824  There  is  
slight  decrease  in  mean  zinc  level  in  subjects  with  rural  residence,  but  it  
was  not  statistically  significant. 
 
Diet  and  Zinc  Level: 
 Mean  zinc  level  in  non-vegetarian  GDM  group  was  59.23 µg / dl   ,  
and  mean  zinc  in  vegetarian  GDM  group  was  63.03 µg / dl.  P  value  -  
0.446.  Mean  zinc  level  was  slightly  higher  in  vegetarian  group,  but  it  was  
not  statistically  significant.    
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RELATIONSHIP  BETWEEN  MAGNESIUM  AND  OTHER  
VARIABLES 
 
Age  and  Magnesium  Level: 
 The  mean  level  of  magnesium  between  20  to  25  years  of  age  was  
1.75  mg / dl  and  between  26  to  30  years  was  1.34  mg / dl.  The  mean  
magnesium  was  lower  in  higher  age  group.  p  value  was  0.103,  it  was  not  
statistically  significant. 
 
BMI  and  Magnesium  Level: 
 Mean  magnesium  level  was  1.69 mg / dl  in  women  with  normal  BMI   
and  in  women  with  overweight  GDM  group  was  1.75 mg / dl  and  the  p -  
value  was   0.714,  not  statistically  significant.  There was  no  significant  
difference  between  these  two  groups. 
 
Family  history  of  diabetes  and  Magnesium  Level: 
 Mean  magnesium  level  in  GDM  group  with  positive  family  history  
of  diabetes  mellitus  was  1.77 mg / dl.  Mean  magnesium  level  in  GDM   
group  with  no  history  of  diabetes  was  1.64 mg / dl.  It  is  higher  in  women  
with  GDM   group  of  positive  family  history. 
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Residence  &  Magnesium  Level : 
 Mean  magnesium  level  in  subjects  of  GDM  group  with  urban  
residence  was  1.77  mg / dl,  whereas  mean  magnesium  in  subjects  of  GDM  
group  with  rural  residence  was  1.50 mg / dl.  The  mean  magnesium  level  
was  lower  with  subjects  in  rural  areas.  The  cause  could  be  an  inadequate  
intake  of  magnesium  rich  food. 
 
Diet  and  Magnesium  Level: 
 Mean  of  magnesium  in  vegetarian  GDM   group  was  1.96 mg /dl ,  and  
in  non-vegetarian  GDM  group  was  1.67mg / dl,  P  value  -  0.151.  There   is  
no  significant  difference  in  magnesium  level  in  both  groups. 
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SUMMARY 
  
SUMMARY 
 Micronutrients  of  zinc  and  magnesium  status  was  assessed  in  GDM  
primigravida  -  women   in  GDM  group  had  lower  zinc  levels. 
 The  mean   serum  zinc  level  in GDM  group  was  estimated  and  was  
59.61 µg / dl. 
 The  mean  serum  zinc  concentration  in  control  group (primigravida  
with  normal  blood  glucose  level)  was  estimated  and  was  69.07 µg / 
dl. 
 The  zinc  levels  in  GDM  group  were  statistically  lower  as  compared  
to  control  group  ( p : 0.000  ). 
 The  mean  magnesium  in  GDM  group  was  estimated  and  was  1.69 
mg / dl,  The  mean  serum  magnesium  concentration  in  control  group  
was  1.74  mg / dl.  The  magnesium  levels  in  GDM  were  lower  but   
not  statistically  significant. 
 Correlation  between  blood  glucose  levels  and  zinc  was - 0.226  and  
correlation  between  glucose  and  magnesium  was - 0.058.  Micronutrient  
concentration  were  negatively  correlated  with  blood  sugar. 
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CONCLUSION 
 
  
CONCLUSION 
 Diabetes  mellitus  occurs  throughout  the  world,  especially                        
type 2  diabetes.  The  increase  in    incidence  in  developing  countries  like  
India  follows  the  trend  of  urbanization  and  lifestyle  changes,  including  
increasingly  sedentary  lifestyles,  less  physically  demanding  work  and  the  
global  nutrition  transition,  marked  by  increased  intake  of  foods  that  are  
high  energy dense  but  nutrient  poor.  The  risk  of  getting  type  2  diabetes  has  
been  widely  found  to  be  associated  with  lower  socioeconomic  status.  
Gestational  diabetes  mellitus  is  a  strong  predictor  of  postpartum  diabetes  
and  transition  to  overt  type 2 diabetes  in  later  life.  So  identification  of  
GDM   is  a  major  health  concern  in  the  society. 
 
        Pregnancy  itself  is  a  state  of  insulin  resistance.  Women  who  
develops  GDM  is  partly  due  to  insulin  resistance  and  partially  due  to  
inadequate  insulin  secretion.  Zinc  is  a  essential  element  for  insulin  
secretion.  Magnesium  is  also  essential  for  insulin  action.  Zinc  and  
magnesium  deficiency  is  one  of  the  preventable  risk   factor   of    diabetes  
mellitus. This  has  important  health  implications  for  diabetic  pregnant  women  
and  their  newborns. From  the  current  study  it  is  found  that  serum  zinc  
levels  were   significantly  less  in  women  with  GDM  compared  to  women  
with  normal  pregnancy  and  the  amount  of  magnesium  in  women  with  
gestational  diabetes  mellitus  was  less  than  control  group,  but  it  was  not  
statistically  significant.  It may  be  due  to  the  duration  of  disease  and  serum  
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magnesium  level  may  be  normal  even  when  intracellular  magnesium  is  
deficient.   
 Diabetes  mellitus  is  a  major  public  health  problem throughout  the  
world  and  is  growing  in  populations,  therefore  should  be  more  attention  to  
be  paid  on  the  concentrations  of  microelements  in  pregnant  women  and  
screening  for  zinc,  magnesium  level  in  pregnancy  is  essential.  
Supplementation  of  zinc,  magnesium  and  encouraging  them  to  eat  zinc  and  
magnesium  rich  food  may  play  a  pivotal  role  in  decreasing  the  incidence  
of  GDM  and  diabetes  mellitus  in  future. 
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LIMITATIONS 
1. In  this  study  food  intake  diary  was  not  included.  Dietary intake  and  
supplementation  of  multivitamins  were  also  important. 
2. No  data  about  preterm  serum  zinc,  magnesium  levels 
3. Further  studies  with  micronutrient  substitution  and  glycemic  control  
in  GDM  would  strongly  help  in  revealing  influence  of  zinc  &  
magnesium  in  glucose  homeostasis. 
 
FUTURE  SCOPE 
 The  current  study  could  be  of  public  health  importance  as  antenatal  
screening  for  serum  micronutrient  status  and  proper  supplementation  of  
zinc,  magnesium  may  prevent  development  of  gestational  diabetes  mellitus,  
control  the  hyperglycemic  status  and  may  reduce  the  risk  of  spontaneous  
preterm  birth  and  other fetal complications. 
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ANNEXURES 
 
  
  
  
  
PROFORMA 
         ID No : 
Name    :  
Age / Sex   : 
Place    : 
Occupation   : 
LMP      :    EDD   : 
Height   :    Weight  : 
BMI    : 
Pulse Rate   :    BP   : 
History of Presenting Illness: 
Past History   : 
Family History of Diabetes  
Mellitus   :  Present   /    Absent 
Personal History  :  Vegetarian  / Non Vegetarian 
General Examination : 
Systemic Examinations :  CVS / RS / CNS 
Investigation done already :  
     75gm OGTT  
     USG Report  
Serum Zinc level   : 
Serum Magnesium level : 
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